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Conditions attributed to the effects of
5-hydroxytryptamine are seen in patients suffering
from certain psychological disorders and in patients
with carcinoid tumours. In the former there may
be too little or too much 5-hydroxytryptamine
present in the brain and in the latter, large
amounts of 5-hydroxytryptamine are produced by such
tumours. There is, therefore, the possibility
that substances which act like 5-hydroxytryptamine
and substances which antagonise 5-hydroxytryptamine
might be of therapeutic use. The study of drugs
which modify the action of 5-hydroxytryptamine is,






The increase in the vasoconstrictor power
of blood after clotting has been known for about a
hundred years. In 1918, Janeway, Richardson and
Park showed that the vasoconstrictor element was
contained in an extract of the platelets to a much
greater extent than in the rest of the blood. In
1948, Rapport5 Green and Page (1948a) Isolated the
substance from blood serum. It caused constriction
of isolated perfused blood vessels and contraction
of isolated intestinal strips. In 1949, Rapport
finally identified the structure of this vasocon¬
strictor element as 6-hydroxytryptamine. It was
synthesized by Hamlin and Fischer in 1951.
A second group of workers, Vialli and Erspamer
(1933), extracted a substance from rabbit gastric
mucosa and called it enteramine. This substance
caused contraction of isolated smooth muscle and
gave a colour reaction after coupling with the dia-
2onium salt of ^-nitroaniline. Vialli and Erspamer
(1933) thought that it originated from the argento-
phil cells of the gastro intestinal tract of mammals.
In 1952, Erspamer and Asero identified this colour-




(i) Isolated preparations t-
The carotid artery ring was the first tiss-
hse to he used for the assay of serum vasoconstric¬
tor element (Janeway and Park, 1912). Woolley and
Shaw (1962) reported that contractions of sheep
carotid artery rings were caused by 0.08 - 0.2 pg./
ml. of 5-hydroxytryptamine.
The rat uterus in oestrous was described by
Erspamer (1940), who used it for the assay of enter-
araine. The technique was simplified by Amin, Craw¬
ford and Gaddum (1964), who used virgin rats and
induced oestrous by injecting stilboestrol a day
before the rat was killed. This tissue responded
to 1 to 10 ng./ml. of 5-hydroxytryptamine. When
atropine was added to the de Jalon solution, no
other drug had much activity in this low concentra¬
tion.
The perfused vessels of rabbit's ear was des¬
cribed by Page (1942), who used this preparation as
a test in the isolation of 5-hydroxytryptamine. It
was more sensitive than the carotid artery rings.
The rat's colon was described by Dalgleish,
Toh and Work (1963). Tests on this preparation,
like those on the rat uterus, are usually made in
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the presence of atropine. This tissue was more
sensitive than the rat uterus in oestrous.
The Venus mercenaria heart was described by
Twarog and Page (1953). It responded to between
2 and 20 ng./ml. of 5-hydroxytryptamine.
The suoerfused isolated anterior byssus retrace
tor muscle of Mvtilus edullis was used by Cambridge
and Holgate (1955). 5-Hydroxytryptamine caused a
rapid relaxation of the electrically stimulated
muscle and the amount present in serum diluted 1-10
times could be detected by this tissue easily.
The superfused guinea pig ileum (in the pres¬
ence of atropine and mepyramlne) was described by
.
Cambridge and Holgate (1955) but its sensitivity to
5-hydroxytryptamine was not very great; the small-
est amount detectable was 20 ng./ml. in the super-
fusion fluid.
The Isolated hearts of molluscs have been
studied by Gaddum and Paa.sonen (1955). The heart o:*
Spisula Solida, in particular, was quite sensitive
to the effects of 5-hydroxytryptaminej it responded
to between 0.1 and 1.0 ng./ml.
The rat fundus strip was described by Vane
(1957) who found it 10-100 times more sensitive to
the action of 5-hydroxytryptamine than the rat uter¬
us in oestrous. The rat fundus strip is the most
sensitive preparation for the assay of 5-hydroxy-
5
tryptamine so far described.
. .. .. v .... .. ,. . . j .,
(ii) Chemical methods
Physico-chemical methods are now being
introduced to isolate and identify 5-hydroxytrypta-
mine. These methods often give quick and reliable
■ '
: ' * I
results. Chromatography has played an important
,
part in the extraction of S-hydroscytryptamine from
■
the tissues. Dalgleish (1956) and Jepson (1965)
have summarised with the help of maps, the spots
produced by substances related to tryptophan metab-
olisra.
Shepherd, West and Ersparaer (1963) used the
production of fluorescent derivatives as a simple
means of detecting 5-hydroxytryptamine on paper
chromatograms. Jepson and Stevens (1953) modified
this method to increase its sensitivity. Blaschko
and Bellman (1953) reported a colour-reaction
(brown) when 5-hydroxytryptamine or tryptamine was
incubated with tissues containing amine oxidase.
The quantitative estimation of the amounts present
depends upon such properties as the production of
fluorescent derivatives of 5-hydroxytryptamine.
The spectrophotofluorometric method of Udenfriend,
Weissbach and Clark (1956) can detect 5-hydroxy-
tryptamine in amounts as small as 50 ng.
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General Pharmacological Effects
(i) On the cardiovascular system:
Blood pressure. Page and MeCubbin (1953)
gave the name "amphibaric" to the type of response
which 5-hydroxytryptamine produces in animals, be¬
cause sometimes it caused a rise and sometimes,
even in the same animal, a fall.
In dogs, the blood pressure usually falls with
slowing of the heart rate. This depression is
followed by a rise and then finally by a prolonged
fall. Page and McCubbin (1953) considered the
Initial fall as a Von Bezold reflex which could be
eliminated by cutting the vagi or by giving atro¬
pine. In cats, there is a sharp and rather pro¬
longed fall in pressure with slowing of the heart
rate. The former effect is partially abolished by
atropine or cutting the vagi.
In rats, the response resembles that in cats.
A transient fall in pressure is followed by a small
rise and this is succeeded by a marked and prolonged
fall (Salmoiraghi, Page and McCubbin, 1956). After
treatment with ganglion blocking drugs or when the
animal is pithed, 5-hydroxytryptamine causes a
large rise in pressure.
Page and McCubbin (1953) concluded that the
depressor response to 5-hydroxytryptamine may be due
to either the release of endogenous histamine by 5-
hydroxytryptamine or/to antagonism of the trans¬
mitted peripheral vasoconstriction.
Hollander, Michelson and Wilkins (1957) inject¬
ed 0.25 to 2 rag. 5-hydroxytryptamine into normal anc.
into hypertensive human beings. They noted an inc¬
rease in the pulse rate but a variable pressor, de¬
pressor or biphasic effect on arterial pressure. Aii
pulmonary
increase in the/ventilation was consistently present|.
Cardiac output, MacCannon and Horvath (1954)
reported that by injecting 5-hydroxytryptamine into
dogs, an increase in both pulmonary and systemic
vascular resistance was obtained. It was quickly
followed by a rise in the cardiac output,
A great increase in cardiac output has been
shown in human beings, by using Fick»s principle
(Page, 1957).
Heart muscle and coronary circulation; Schofield
and Walker (1953) found that 5-hydroxytryptamine anc.
noradrenaline were equal in potency to adrenaline in
causing vasodilation of the perfused anterior des¬
cending branch of the left coronary artery of dogs.
Bulle (1957) produced cardiac infarct by simply
injecting 5-hydroxytryptamine or serum into the left
ventricular wall of a perfused rabbit heart. (Chlor-
proraazine prevented this, but reserpine did not).
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Effect of 5-hvdroxvtrvptamine on special vascm-
lar areas; Haddy, Fleishman and Manuel (1967)
have shown that adrenaline and noradrenaline caused
constriction of the dog's fore-leg small vessels
while 5-hydroxytryptamine caused their dilatation.
5-Hydroxytryptamine also caused constriction of the
large arteries and veins. Maglini et al (1966)
found that 5-hydroxytryptamine caused a local rise
in venous pressure in man. Page (1964) reported
that 6-hydroxytryptamine is roughly one-tenth as
active as adrenaline on the rabbit ear vessels.
Rondel et al (1967) found that the response of the
blood vessels of the rabbit's ear to 5-hydroxytryp-
tamine was not given by pitres3in or acetylcholine.
Eoddie et al (1965) injected 5-hydroxytrypta-
mine into the brachial artery of normal human beings
and found that it produced a decrease in the blood-
flow in the fore arm and hand with marked reddening
of the skin and blueness in the fingers. They
supposed that 6-hydroxytryptamine caused constric¬
tion of the vessels concerned with peripheral resis¬
tance, but dilates the minute vessels of the skin.
Effect on pulmonary circulation; Ginzel and
Xottegoda (1963) reported that 6-hydroxytrptamine
caused vasoconstriction in dogs' and cats' lungs
and was more active than adrenaline and noradrena¬
line, Rudolph and Paul (1967) showed conclusively.
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that in dogs 5-hydroxytryptamine was a direct vaso¬
constrictor of the pulmonary vessels.
:..0 Baldrighi and Ferrari (1955) injected S^hydrox
ytryptaraine intravenously into human beings and
showed an Increase in venous right atrial and pulm¬
onary arterial pressures. The heart rate and
stroke volume was also increased in most cases.
Smith and Smith (1955) injected, intravenously into
animals, clots formed in vitro and noted more pro¬
found circulatory effects than with an ordinary
suspension of starch granules. 5-Ifydroxytryptamine
antagonists diminished the effect of the injection
of clots and they concluded that 5-hydroxytryptamine
was involved in the vascular effects of pulmonary
embolism.
McCubbin et al (1956) have tried to clarify the
chemoreceptor stimulant effect of 5-hydrcxytrypta-
mine and have shown that small doses of 5-hydroxy-
I tryptamine failed to stimulate respiration unless
the drug reaches the chemoreceptors, which are
present somelwhere in the path of the circulation
between the large veins and the left atrium or the
ascending aorta. Much larger doses, after section
of the sinus nerves, caused the reappearance of a
respiratory response? the mechanism of this last
mentioned phenomenon, seemed to be central. It
persisted after cervical section of the spinal cord
10
and section of the vagus aortic and sinus nerves.
(11) On the respiration; This varies from onfe
species to another. Beid and Rand (1958a and b)
and Beid (1952) found that when 5-hydroxytryptaiaine
was injected into the right atrium of an anaesthet¬
ised dog with intact vagi, there was a brief period
of 30 sec. of apnoea followed by tachypnea and sim¬
ultaneous vasoconstriction of the bronchi.
Schneider and Yonkman (1953 and 1954)j Mott
and Paintal (1953) and Gomroe et al (1953) suggested
from their experiments that 5-hydroxytryptamine act$
on the receptors situated in the circulation between
the large veins and the left atrium or the ascending
aorta. VJhen these receptors are stimulated by 5-
hydroxytryptamine, the afferent vagal fibres which
originate from them cause reflex apnoea. Comroe et
al (1953) considered that these 5~hydroxytryptamine
receptors were different from those affected by Ver«*
atridine , because they could block the 5-hydroxy-
tryptamine receptors with 5-hydroxytryptamine antag¬
onists. Ginsel and Kottegoda (1954) obtained res¬
ults which showed that excitation of these chemo-
reeeptors (in the aortic and carotid sinus) cause
excitation of respiration and that the resulting
apnoea is of central origin.
In dogs, the situation is different. Douglas
and Toh (1958, 1953)| Heymsns and Keymans (1953)|
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Page (1962) and Schneider and Yonkman (1964) found
that in normal dogs, the injection of 5-hydroxy-
tryptamine regularly produced a transitory stimu¬
lation of respiration followed in half the animals
by a period of apnoea, The mechanism of this
action is still unsettled but the last mentioned
authors think that the initial respiratory stimu¬
lation is primarily due to a cardiopulmonary reflex,.
Herxheimer (1963) has shown the direct broncho;-
constrictor effect of 6-hydroxytryptaaine in guinea
pigs by making them inhale a 1% aerosol of 6-hydrox-
ytryptamine. The bronchospasm produced in this way
is antagonised by lysergic acid diethylamide and
atropine but lysergic acid diethylamide has no
protective action against anaphylactic shock (Herx-
heimer, 1966).
(iii) Other effects on the kidneys; Erspamer
and his associates have investigated the effects of
5-hydroxytryptamine on the kidney in detail (Erspamr
er and Qttoleughi, 1960-1953). Erspamer (1964)
concluded that the antidiuretic effect of 5~hydroxy-
tryptamine was due to a preferential vasoconstrict¬
ion of the different glomerular arterioles. He con¬
sidered 5-hydroxytryptamine as a hormone designed
for the physiological regulation of renal function.
Pickford (1957) reported on her work done with
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Abraham (1956) in conscious dogs. There was an
antidiuretic effect with 5-hydroxytryptaraine only
when its injection raised the blood-pressure and
thus reduced the glomerular filtration rate and
renal plasma flow. This suggested that these res¬
ponses were of reflex origin and that the blood
vessels of the kidney show no particular sensitivity
to 5-hydroxytryptamine.
(iv) On the central nervous system; Whether
5-hydroxytryptaraine has any function in the central
nervous system or not is still in dispute, but
experimental evidence strongly suggests that it has>
In 1943, Hofmann discovered that small quantities of
lysergic acid diethylamide (inhaled by accident in
the laboratory) caused hallucinations and a peculiar
state apparently similar to drunkenness in man.
Gaddum (1953b) showed that lysergic acid diethylamide
antagonised the effects of 5-hydroxytryptamlne on
the isolated rat*s uterus preparation and suggested
that there might be a connection between this prop¬
erty and the ability to cause hallucinations. 5-
Hydroxytryptamine had been shown to be present in
the brain by Amln, Crawford and Gaddum (1954) and
independently by Twarog and Page (1953). Gaddum
(1953a) suggested that hallucinations caused by
lysergic acid diethylamide might arise from its
antagonism of the effects of 5-hydroxytryptamine in
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the brain. Woolley and Shaw (1964a), independently
suggested that substances which antagonised 5-
hydroxytryptamine caused "mental aberrations".
Since then, substances have been found such as
ergoiaetrine, dlbenamine and bromolysergic acid
ethylamide which antagonise 5-hydroxytryptamine on
Isolated tissues but which do not produce effects
on the central nervous system. In addition, sub¬
stances, such as mescaline, have been found to pro¬
duce effects on the brain somewhat similar to those
of lysergic acid diethylamide but not to antagonise
the effects of 6*hydroxytryptaniine on the rat uterus
(Gaddum, 1967b), These findings are not what would
be expected if there is a connection between the
ability to antagonise 5-hydroxytryptamine but as
Gaddum (1967b) remarks, "They do not disprove the
theory.....but they do diminish the value of the
existing evidence favouring the theory",
ILB. Costa (1966) reported that a concentration
of lysergic acid diethylamide lower than 1 ng, per
ml. caused facilitation of the responses of 6-hydro-
xytryptamine on the rat uterus, in addition to the
antagonistic action at higher concentration, and
that this effect was also shown by mescaline in a
concentration of 100 ng. per ml. He suggested that
this facilitation was the typical effect of drags
which caused hallucination. He also observed antag¬
onism between 5-hydroxytryptamine and certain tran¬
quillisers like reserpine, chlorpromaalne and asacy
clonal. Cerletti and Doepfner (1968) failed to ob¬
tain such a facilitation with lysergic acid diethyl
amide on the rat uterus and I also, have not been
able to repeat Costa's results with lysergic acid
diethylamide.
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Peldberg and Sherwood (1954) reported the
effects of 5-hydroxytryptamine introduced into the
cerebral ventricles of conscious cats. Doses of
75-500 ji.g, 5-hydroxytryptamine produced loss of
muscular tone, tachypnea, licking movements, bursts
of profuse salivation, tremors of head and twitching
of eyelids. Gaddum and Vogt (1956) repeated this
work and found, further, that the depressant action
of 5-hydroxytryptamine in the brain of cats was
antagonised by lysergic acid diethylamide, ergo-
metrine, morphine, methadone and amphetamine, Brorao-
lysergic acid diethylamide, 5-hydroxytryptamine and
methyl medmain were without such an effect. They
concluded that this type of antagonism was probably
not related to the antagonism of 5-hydroxytryptamine
by lysergic acid diethylamide on peripheral tissues.
( See section on antagonists on page 30).
Vogt (1957) reported the interaction of 5-
hydroxytryptamine and lysergic acid diethylamide in
the brain in experiments where multiple electrodes
were introduced into the brain of cats. Records
were made of the e.e.g, changes when 5-hydroxytrypt¬
amine was injected into the lateral ventricles,
either alone, or in combination with lysergic acid
diethylamide (Vogt, Gunn and Sawyer, 1957), A re¬
duction in the amplitude of electrical activity was
IS
noted in most of the areas. In these experiments,
5-hydroxytryptaraine and lysergic acid diethylamide
each caused a characteristic pattern of electrical
changes, which coincided in time with the behaviour*-
al changes observed in conscious cats. When the
drugs were given together, the effects were additive
at some sites and antagonistic at others. These
findings favour the theory that antagonistic effects
of S-hydroxytryptamine and lysergic acid diethylamide
on behaviour depends on selective sensitization or
inhibition of a characteristic group of centres by
each drug and not on simple interaction by competi¬
tion for the same receptors within the brain.
Shore, Silver and Brodie (1956a and b) and
Brodie et al (1956) observed that 5-hydroxytrypta-
mine and reserpine both markedly increased the hyp¬
notic action of hexobarbitone in mice and that both
these effects are antagonised by the prior admini¬
stration of lysergic acid diethylamide. After res-
erpine, the 6-hydroxytryptamine content of certain
tissues, such as the brain and platelets is lowered
and it has been suggested that the tranquillising
effect of reserpine may be due to the liberation of
5-hydroxytryptamine in the brain.
Gaddurn and Giarman (1956) have shown the pres¬
ence of 5-hydroxytz-;/pophan decarboxylase, which
forms 5-hydroxytryptamine, in different tissues,
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including some parts of the train, Bogdanski et_
(1957) have shown an apparent relationship between
5-hydroxytryptamine and the decarboxylase activity
in the brain, suggesting that 5-hydroxytryptamine i$
synthesised in the brain, Benitz, Murray and
Woolley (1955a and b) reported that the rat and
human oligodendroglia cells in tissue cultures were,
thrown into strong contractions by the addition of
5-hydroxytryptamine to the nutrient fluid. Woolley
and Shaw (1957a) suggest that this phenomenon is
the cerebral counterpart of the effects of 5-hydrpx-
ytryptamine on the smooth muscles.
Gieger (1957) described a pumping movement in
human and rabbit neurones grown in tissue cultures
which is initiated by 5-hydroxytryptamine in concen¬
tration of 0.5 to 2 jig. per ml.
Yet another aspect of the action of 5~hydroxy-i
tryptamine in the brain was shown by Marrazzi and
Hart (1955) who found that 5-hydroxytryptamine, like
adrenaline and noradrenaline, blocked synaptic trans¬
mission in the brain. It was actually the most
active of these inhibitors. Gluckaan, Hart and
Marrazzi (1957) showed that the cerebral synaptic
inhibitory activity of 5-hydroxytryptamine was 20
times that of adrenaline but, on the ciliary gang¬
lion 5-hydroxytryptamine was much less active.
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Bradley (1957) studied the effects of S-hydroxyj-
tryptamine on the behaviour of conscious cats and
the electrical activity of the brain. Small doses
of lysergic acid diethylamide, which only "alerted"
the animal did not antagonise the effects of 5-
hydroxytryptamine but larger doses of lysergic acid
diethylamide, such as used by Gaddum and Vogt (1956)
did do so* The combination of 5-hydroxytryptamine
and lysergic acid diethylamide together produced a
new pattern of electrical activity, different from
those of either drug alone, Bradley considered
that 5-hydroxytryptamine affected the centres influ¬
encing the e.e.g. less than other areas of the
central nervous system.
(v) On the adrenal medulla: Reid and Rand
(1952a,b) found that 5-hydroxytryptamine, when
injected into the cut stump of the superior mesentei
ic artery of the eviscerated cat, caused a discharge
of adrenaline from the adrenal medulla. There was
a rise in blood pressure, increase in heart rate,
dilatation of the pupils and contraction of the
nictitating membrane, Reid (1952) also showed thai,
tryptamine did not do this, whereas bufotenine and
bufotenidine (Raymond Mamet, 1942-1943) did it to a
greater extent even than 5-hydroxytryptamine.
(vi) Histamine releases Feldberg and Smith
(1953) showed that 5-hydroxytryptamine and trypta-
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mine released histamine in perfused isolated skin
flaps and gastrocnemius muscles of cats and dogs,
as well as on rat tissues. Their activity was only
l/lOO times that of compound 48/80. This does not
exclude the possibility that histamine release is
at the root of certain phenomena, resembling the
effects of histamine, which are seen in Intact
animals after they have been injected with the
tryptamine-like compounds,
(vii) On coagulation of the blood; Correll et
al (1968) studied the haemostatic effect of 5-
hydroxytryptamine in the blood of rats, guinea pigs,
chickens and rabbits and showed that it had marked
activity, but that the effect was short lived. Page
(194S) also suggested such an effect. Shore et al
(1966) reported that reserpine treatment, which
resulted in the loss of 90^ of platelet 5-hydroxy-
tryptamine, did not produce any significant effect
on the bleeding time in rabbits, rats and guinea
pigs. So the participation of 6-hydroxytryptamine
in the process of blood coagulation is still not
clear.
(viii) On the capillary permeability: Bowley
and Benditt (1966) have shown in rats (which had
already received injections of Vital dye) that a
subcutaneous injection of 5-hydroxytryptamine pro-
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dueed a marked .Increase in capillary permeability.
This latter effect was shown by the local exudation
of the Vital dye at the site of injection of the 5-
hydroxytryptamine. They have also shown that 5-
hydroxytryptamine was 200 times as effective as
histamine in producing oedema in the rats» paw.
Sparrow and Wilhelm (1957) found that this effect
of 5-hydroxytryptamine varied greatly from one
species to another. It was very marked in rats
but not in guinea pigs and rabbits.
(xi) On the gastro-intestinal tract: Long
before the true nature of 5-hydroxytryptamine was
identified, Erspamer and Vialli (1933) had shown
that enteramine was present in the rabbit*s gastric
mucosa. Since then, its distribution in the gast
intestinal tract in various animals and human beings
has been thoroughly investigated by Erspamer and
others (work reviewed by Erspamer,(1954)« Feldberg
and Toh (1953) and Dalgleish, Toh and Work (1963).
It is distributed widely in the mucosa of the gastro
intestinal tract of the different species.
Erspamer (1954) states that 5-hydroxytryptamine
is formed in the enterochromaffin cells of the
gastro intestinal mucosa and is released into the
circulation where it is taken up by the platelets.
5-Hydroxytryptamine stimulates the smooth muscles
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of some parts of the gastro intestinal tract in
certain species (Erspamer, 1954} Vane, 1967). The
sensitivity of the different tissues varies greatly ,
The guinea pig ileum is extensively used by various
workers in the 5-hydroxytryptaraine field. Gaddum
(1953a) postulated that 5-hydroxytryptamine and
tryptamine cause contraction of this tissue by act¬
ing on the same set of receptors. A large dose of
5-hydroxytryptamine desensitised the preparation to
5-hydroxytryptamine and tryptamine, but substance P
was still active. On the other hand, a large dose
of substance P left the tissue insensitive to the
action of substance P but it responded to 5-hydroxy¬
tryptamine and tryptamine. Rocha e Silva, Valle
and Picarelli (1953) concluded that the action of 5-
hydroxytryptamine on the guinea pig ileum was choli¬
nergic in origin because it was blocked by atropine*
This cholinergic effect was not blocked by hexa-
methonium, so presumably it was not at the ganglion*
The provisional conclusion dvaxm was that 5-hydros-
tryptamine acted on the post ganglionic fibres of
the intra nervous system, more peripherally than
where nicotine acts.
Gaddum and Hameed (1954) failed to get total
suppression of 5-hydroxytryptamine responses by
lysergic acid diethylamide on the guinea-pig ileum.
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Increasing the concentration of lysergic acid di¬
ethylamide 100 times did not increase the antagonism
to 6-hydroxytryptamine. They suggested that 5-
hydroxytryptamine receptors in the guinea pig ileum
were different from the 5-hydroxytryptamine receptors
in the rat uterus and the rabbit ear vessels, be¬
cause of their resistance to the action of lysergic
acid diethylamide and their easy paralysis by exces
of 5-hydroxytryptamine itself.
Cambridge and Holgate (1965) made similar obs¬
ervations with atropine. They plotted the responses
to a constant dose of 5-hydroxytryptamine, histaminfe
and acetylcholine against the logarithm of the dose
of atropine. The curves obtained with 6-hydroxy-
tryptamine had a plateau over the range of concen¬
tration 0.01 to 1,0 p,g./ml, of atropine, while the
curves obtained with histamine and acetylcholine
were both simply S-shaped.
Gaddura and Picarelli (1957) classified the'
actions of 5-hydroxytryptamine on the tryptamine
receptors in the guinea pig ileum as being of two
types: a) at "M" receptors which were blocked by
morphine and b) at 11D" receptors which were blocked
by dibenzyline, Atropine, cocaine and methadone
blocked the effect of 5-hydroxytryptamine on the
M" receptors, i.e. after the action of dibenzyline
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but had no additional effect after morphine.
Lysergic acid diethylamide, dihydroergotamine and fi¬
feenzyloxygramine blocked the effects of 5-hydroxy-
tryptamine on the "D" receptors, i.e. after morphine,
but were without any effect after dibenzyline. The
morphine sensitive receptors were probably in the
nervous tissue and the dibenzyline sensitive recep¬
tors were probably in the muscle.
Gaddum (1957a) compared the mode of action of
5-hydroxytryptamine with that of acetylcholine.
Both drugs act on two different types of receptors
which are blocked by two separate groups of antag¬
onists. The ganglionic effect of acetylcholine
was compared with the action of 5-hydroxytryptamine
on the "If1 type of receptors in the guinea-pig
ileum. The former was specifically blocked by hexa-
methonium and the latter by morphine, less specifi¬
cally, because nicotine is also blocked to some
extent. Similarly, atropine blocked the effects
of acetylcholine on the smooth muscle while lysergic
acid diethylamide blocked the effect of 5-hydroxy¬
tryptamine on the plain muscle of the guinea pig
ileum,
Kosterlitz and Robinson (1955) showed that the
contraction of the guinea pig ileum caused by the
application of 5-hydroxytryptaraine to the bath was
different from the one obtained by filling the
lumen of this tissue. The latter was not blocked
by dlbenamine, cocaine or by large doses of 6-
hydroxytryptamine. Both types of contractions
were partially inhibited by morphine. Kosterlitz
and Robinson (195?) also showed that small amounts
of 6-hydroxytryptaraine added to the outside of the
intestine depressed or even abolished the peri¬
staltic reflex. Bttlbring and Lin (1957) confirmee
that 5-hydroxytryptaraine added outside the intest¬
ine blocked peristalsis but when added inside the
lumen of the guinea pig ileum, it caused an increase
of peristaltic movement and a lowering of the
threshold pressure. The contractions obtained
were more frequent and a larger volume of gluid was
propelled. Bftlbring and Lin (1957) suggested
that 5-hydroxytryptaraine acted on the sensory rec¬
eptors in the mucosa, which trigger the peristaltic
reflex, and that the formation of 5-hydroxytrypta-
mine by intestinal mucosa may be part of the mech¬
anism required for peristalsis.
According to Page (1954) it has been known
for a very long time that 5-hydroxytryptamine
causes evacuation of the bowels even in animals
under deep anaesthesia. This effect was noted in
experimental animals by Erspamer (1958) and con¬
firmed by Collier (1957). A dose of 5 mg./kg. of
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6-hydroxytryptamine injected into mice caused an
increase in the number of faeces passed within four
hours of treatment. Some mice passed unformed
faeces, " as much as with a large dose of senna".
These facts, together with the presence of diarrhoea
in patients with carcinoid tumours, prompts the
question - "Is 6-hydroxytryptamine nature's remedy
for constipation?" (Collier, 1967).
Black, Fisher and Smith (1968) found that 5-
hydroxytryptamine, when intravenously infused in a
dog for 46-90 mins. did not evoke acid gastric
secretion but only the secretion of mucous. Hista¬
mine evoked acid gastric secretion was inhibited
by a concurrent infusion of 6-hydroxytryptamine for
30 mins. but giving 5-hydroxytryptamine at the
start of such a histamine infusion did not prevent
the response when both the vagi in the neck were
cut. 6-Hydroxytryptamine did not inhibit histamine-
stimulated secretion
Distribution of 5-hydroxytryptamine
The distribution of 6-hydroxytryptamine has
been reviewed by Ersparaer (1964). It is present
in all the tissues containing cells belonging to thq
enterochromaffin system. It has been found in a
number of vertebrates, except in Teleosteiand Cyclo-
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stomata (groups of fish), which do not contain
enterochromaffin cells.
Its occurrence in the intestine of a number of
species has been reported by Erspamer and Faustini
(1953). Dalgleish, Toh and Work (1953) found 4-10
P<g./g» in the dog's muscularis-mucosa but none in
the muscularis-externa.
It was shown to occur in the brain by Twarog
and Page (1953) and, independently, by Amin, Craw-
for and Gaddum (1954), The latter found the dis¬
tribution resembled that of noradrenaline found by
Vogt (1954).
The platelets are very rich in 5-hydroxytrypta*-
mine. Humphrey and Toh (1954) found that dog's
/ -9
platelets contain 0,5 - 2.7 p.g./10 platelets but
the rest of the blood contains only a very small
quantity of 5-hydroxytryptamine,
Garven (1955) found significant quantities in
the spleen and serum of rabbits (as well as in the
gut mucosa and blood). A smaller amount was pres-
ent in the hypothalamus, liver and bone-marrow.
Skeletal muscle, nerves and adrenals contained no
5-hydroxytryptamine,
The amounts in lung tissue have been studied
by Weissbach, Waalkes and Udenfriend (1957), who
found very little in guinea pig lung but much more
































5 - HYDROXYINDCLE-3-ACETIC ACID
Various pathways of 5-hydroxytryptaiaine metabolism
(Udenfriend (19571
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In invertebrates? it has been found in ganglia
and peripheral nerves of Sepia (Plorey and Florey,
1963, 1964? and Florey, 1964), and in the visceral
ganglia of Venus mercenaria (Welsh, 1964). It
occurs in large quantities (6 mg./g,) in carcinoid
tumours (Lembeck, 1963), and is present in mast
cells of rats (Benditt et al, 1966) and, in large
amounts along with histamine, in mast cell tumours
in mice (Sjoerdsma, Waalkes and Weissbach, 1967).
It has also been found in the spinal fluid of
patients with head injuries, brain tumours and menin¬
gitis and in dogs and cats with head injuries
(Sachs, 1967).
Apart from numerous sources listed by Erspamer
(1964a,b), 6-?hydroxytryptaraine has been found in
certain venoms. Jaques and Schachter (1964) found
it in the tentacles of the sea anemone and in wasp,
but not bee, venom. Collier and Chester (1966)
found 6-hydroxytryptamlne together with an inacti¬
vating enzyme, in nettle stings and Adam and Weiss
(1966) found as much as 304 pg./mg. (dry weight) in
scorpion venom.
Metabolism of 5-hvdroxytrvptamine
Fig, I shows the way in which 6-hydroxytrypta-
mine may be formed and broken down in nature. Trypto¬
phan is oxidised to 6-hydroxytryptophan:'n the toad
and in chromobacterium violaceum (Mltoma et al,
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1955, 1956). 5-Hydroxytryptophan, which can pass
the blood brain barrier (Udenfriend et al. 1966,
1967), appears to be an intermediate in the synthesis
of 5-hydroxytryptamine. When fed to animals, there
is a large rise in the 5-hydroxytryptamine content
of the brain and when it is given to human beings
there is a large rise in the excretion of 5-hydroxy-
indole acetic acid (Davidson et al. 1957). 5-
hydroxytryptophan decarboxylase, which would conver
5-hydroxytryptophan into 5-hydroxytryptamine, is
widely distributed throughout the body. It occurs
in large amounts in the kidney, liver and stomach
but not in platelets (Udenfriend and Weissbach,
1954). It is also found in sympathetic ganglia
and in the brain (Gaddum and Giarman, 1956), where
its distribution is reported to be similar, in dogs
and cats, to that of 5-hydroxytryptamine (Bogdanski
Weissbach and Udenfriend, 1957), except in the
pyriform cortex and amygdala. The caudate nucleus
contains the highest decarboxylase activity.
Tryptamine is known to be destroyed by amine
oxidase in vitro (Blaschko, Richter and Schlossmann
1937| Pugh and Quastel, 1937), and this enzyme
might be expected to attack 5-hydroxytryptamine also.
Rapport, Green and Page (1948b) found that serotonin
was destroyed by lung extracts and Blaschko (1952)
showed that serotonin and enteramine (5-hydroxy-
*iet&
tryptaraine)/inactivated by amine oxidase. This
enzyme is widely present in mammals, especially in
the brain, but is absent from blood and skeletal
muscle (Blaschko, 1957), It is present in the rat
fundus strip (Vane, 1959),
This enzyme also destroys mono-methyl trypta-
mine, in which the methyl group is attached to the
side-chain amino group, but will not destroy, and
is inhibited by, the analogous dimethyl, diethyl or
benzyl compounds (Gover, Howes and Gibbons, 1953),
If 5-hydroxytryptamine is destroyed by amine
oxidase, this would explain why Marsilld, an amine
oxidase inhibitor, potentiates the effects of 5-
hydroxytryptamine (Udenfriend et al, 1957), Sjoerd-
sma et al (1955) are convinced that oxidative deam-
ination by amine oxidase is the major metabolic
pathway of 5-hydroxytryptamine,
The product of oxidation is 5-hydroxyindole
acetaldehyde which should be rapidly oxidised to 6-
hydroxyindoleaeetle acid. Excretion of this com¬
pound appears to be the main route of disposal in
man but in other species urinary output is small
and other pathways must be considered (Udenfriend,
1957), Titus and Udenfriend (1954) reported
excretion rates per day of 2-3 mg. 5-hydroxylndole-
acetlc acid for dogs and 10 mg, for man. It is
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excreted in larger quantities by patients with mal¬
ignant carcinoids but in smaller amounts (1-1.9 mg./
day) by patients with collagen vascular disease
(Haverback, Sjoerdsma and Terry, 1966).
Carcinoid tumours
In 1962, Biorck, Axen and Thorson reported a
19-year old man suffering from dyspnoea and a curious
type of cyanosis. The post mortem examination rev¬
ealed pulmonary valvular stenosis and an ileal
argentaffinoma with secondary deposits in the liver.
An addendum was added to the paper describing two
more cases, Lembeck (1963) demonstrated the
presence of 6-hydroxytryptamine in the carcinoid
tumour. It was evident that the signs and symptoms
of carcinoid tumours were due to hypersecretion of
5-hydroxytryptamine and Page et al. 1966 reported
the excess excretion of 6-hydroxyindoleacetic acid
in these patients. The serum 6-hydroxytryptamine
content of carcinoid cases has been shown to be
high by various workers (Duncan et al. 1965j Pernow
and Maidenstr6m, 1957 and Waldenstrom et al. 1966)
and Lembeck and Heubold (1355) have also shown that
patients with carcinoid tumours excreted high quan¬
tities of 6-hydroxytryptamine in urine. Pernow and
Waldenstrom (1957) have suggested that histamine
liberation might also contribute to the symptoms of
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carcinoid disease. Udenfriend et al. (1956)
reported that of the dietary tryptophan at a
daily in take of 500 mg. is converted to urinary 5-
hydroxyindoleacetic acid in patients with carcinoid
tumour. In normal individuals only 1% of trypto¬
phan is metabolised in this way. Mattingly (1956)
reported that actually only 25% of all patients wit
malignant carcinoids of the small intestine, show
clinical symptoms.
Page (1958) has concluded that none of the
antagonists so far available have been successful
in the treatment of patients with malignant carcin¬
oids. "Often they work in isolated preparations
with high specificity, only to be ineffective in
the whole organism'.
Antagonists of 5-hydroxytryptamine
(i) Lysergic acid derivatives; Hofmann's dis¬
covery of the central effects of lysergic acid di¬
ethylamide showed that this was an interesting com¬
pound, but it was Gaddum (1953b) who showed that
this property might be due to its antagonism of
the action of 5-hydroxytryptamine and who shox*ed
that lysergic acid diethylamide was an antagonist
of 5-hydroxytryptamine on the rat uterus. Gaddum
and Hameed (1954) found lysergic acid diethylamide
to be an active and specific antagonist to the
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action of 6-hydroxytryptamine on the rabbit ear but
on the guinea pig ileum lysergic acid diethylamide,
in a concentration of 100 ng./ml. reduced the 6-
hydroxytryptamine responses by 50^ only. Concen¬
trations of lysergic acid diethylamide 100 times
more did not have any additional effect on 5-
hydroxytryptamine responses on the guinea pig ileum.
This finding led them to suggest the two sets of 6-




the action of 6-bydroxytryptamine on the rat uterus
(Sollero, Page and Salmoiraghi, 1966 and Savini
(1966) showed that BGL blocks the vasoconstrictor
action of 6-hydroxytryptamine on the perfused
rabbit ear and on this preparation is l/lOth as
active as lysergic acid diethylamide. Unlike
lysergic acid diethylamide and ergometrine it never
caused vasoconstriction itself, Cerletti and
Konzett (1966) have investigated the antagonistic
properties of a number of derivatives of lysergic
acid diethylamide on the isolated rat's uterus and
perfused rat's kidney. Acetyl- and Bromo-lysergic
acid diethylamide were the most active compounds.
Lysergic acid diethylamide antagonised the anti¬
diuretic effect of 6-hydroxytryptamine in rats
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(Del Grego, Mas son and Corcoran, 1966), and partially
prevented asthma caused by aerosols of 5-hydroxy-
tryptamine in guinea pigs (Herxheimer, 1955). An¬
other potent compound is 1-methy1-2-bromo-lysergic
acid diethylamide (Cerletti and Doepfner, 1958).
Salmoira.ghi, McCubbin and Page (1956) found
species differences in the ability of lysergic acid
diethylamide and bromo-lysergic acid diethylamide
to effect the vascular action of 5-hydroxytryptamlne.
Both the compounds prevented the pressor and de¬
pressor responses to 5-hydroxytryptamine over long
periods in the rats, but in dogs, much larger doses
of bromo-lysergic acid diethylamide caused only
transient and irregular blockade. In cats, both
these drugs failed to have any effect against the
pressor responses to 5-hydroxytryptamine while in
the isolated vascular beds of cats, both the drugs
were more effective to block the action of 5-
hydroxytryptamine,
Ergotamine was shown to block the vasocons¬
trictor effect of defibrinated blood by Heymans,
Bouckaert and Moraes (1932) and Page and McCubbin
(1953) reported that this drug reversed the pressor
action of 5-hydroxytryptamine while increasing the
pressor action of some other drugs. Gaddum (1953c)
found dihydroergotamine to be an active antagonist
33
of 5-hydroxytryptamine on the isolated rabbit ear
preparation. Shaw and Woolley (1953) found that
yohimbine, ergotamine and ergotoxine antagonised th$
effects of 5-hydroxytryptaraine on the carotid artery
rings, Savini (1956) reported that ergotamine an¬
tagonised the constrictor effect of 5-hydroxytrypta-
mine on the isolated rabbit ear preparation and Page
and McCubbin (1953) reported that yohimbine blocks
the pressor action of 5-hydroxytryptaraine in dogs.
(ii) Adrenergic blocking drugs- Dibenaraine ha^
been reported to be a powerful antagonist to 5-
hydroxytryptamine in its action on the rat*s uterus
and in its antidiuretic effect (Brspamer and Corr-
eale, 1953; Flngl and Gaddum, 1953). This compound
is known to have a prolonged antagonistic effect
against adrenaline and some antihistamine effect
also (Nlckerson, 1949). Gaddum and Hameed (1954)
found that it blocked the action of 5-hydroxytrypta-
mine on the rat uterus much more than on the iso¬
lated rabbit ear and guinea pig ileum. Furchgott
(1954) studied the effect of dibenamine on the con¬
tractile responses of strips of rabbit aorta, pro¬
duced by a variety of stimulating drugs. It was
most effective against the sympathomimetic amines
and then in order of decreasing effectiveness against
5-hydroxytryptamine, histamine and acetylcholine.
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He has shown that by keeping a high concentration
of one of the above mentioned stimulant drugs in
the bath, during exposure of the strips to dibena-
mine, he obtained partial or even complete protect¬
ion against the blocking effect of dibenamine. This
he called "self-protection" and suggested that di¬
benamine exerted its blocking action by reacting in
an essentially irreversible manner with the free
receptors, ■with which the stimulant drugs combined
and caused contraction.
Dibenzyline, another antiadrenaline drug, has
been shown by Gaddum and Picarelli (1957) to block
one set of 5-hydroxytryptaraine receptors in the
guinea pig ileum, more or less permanently. Res¬
ponses to histamine were also effected with such
treatment with dibenzyline but not those to nicotine
Holzbauer and Vogt (1955) found substances which had
antagonised the inhibitory action of adrenaline on
the rat uterus. All the nine substances, which
they studied, also antagonised 5-hydroxytryptamine
but did not disturb responses to choline esters.
They did not find a substance which blocked 5-
hydroxytryptamine without also blocking adrenaline.
They pointed out the complete unpredictability of
the effects which even chemically related drugs




















(ill) Analogues of 5-hvdroxytryptamine, The
first synthetic analogues of 6-hydroxytryptamine to
be tested were prepared by Woolley and Shaw (1952a,
1952b) who referred to these substances as 'anti¬
metabolites" . They reported that 2-methyl-3-ethyl-
5-amino indole was an antagonist of S-hydroxytrypta-
mine on pieces of the carotid artery of sheep. This
compound, when fed to dogs in 500 mg. daily doses
for 5 days, prevented the pressor response to
injected 5-hydroxytryptaraine but Spies and Stone
(1952) and Page and McCubbin (1953a) failed to
demonstrate any change in the blood pressure of
hypertensive patients with this compound. Iverson
and Bui (1953) found 2i3-dimethyl-5-amino indole
ineffective in hypertensive cases although this
compound was shown by Woolley and Shaw (1953) to
prevent the rise in blood pressure in dogs due to
5-hydroxytryptamine even when given by mouth.
Shaw and Woolley (1954) found that substitution
of methyl or other alkyl groups to the amine group
in 2 methyl-3-ethyl-5-amino indole compounds gave
very active antagonists of 5-hydroxytryptamine.
Medmain (2-methyl-3-ethyl-5-diiaethylamino Indole)
and its 1 methyl derivative were about 250 times as
active as the parent, unalkylated amine (2-methy1-3-■
ethyl-5-amino indole). Medmain was a very active
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antagonist of 5-hydroxytryptamine on the carotid
artery and isolated rat uterus. When added to the
bath in concentrations higher than that required to
block the action of 5-hydroxytryptamine, the ana¬
logue itself caused stimulation of the uterus (this
was not seen on the carotid artery rings).
The closely related compound, 1-methylmedmain
did not have this stimulant property. Contractions
produced by medmain on the rat and guinea pig uter¬
us were antagonised by 2-methyl-3»ethy1-6-amino
indole, 3~(£-dimethylaminoethyl)-5-amino indole
(Shaw and Woolley, 1954) also, like medmain, antag¬
onised the effects of 5-hydroxytryptamine and stim-
iilated the tissue in higher concentration. The
stimulant action of medmain usually took the form
of repeated contractions of the rat uterus, which
persisted even after repeated washings.
Intraperitoneal injections of medmain into
mice resulted in convulsions but 1-methylmedmain,
which does not have any stimulant action, did not
cause any convulsions In mice. Woolley and Shaw
suggested that these convulsions might be a 5-
hydroxytryptamine-like effect of medraain in the
central nervous system.
Page and McCubbin (1953b) found that medmain
inhibited the pressor but not the depressor action
of 5-hydroxytryptamine in dogs and cats and it
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prevented respiratory stimulation as well. However,
it had no effect in dogs by mouth and when fed to
hypertensive dogs and patients with malignant
hypertension did not prove of any value.
Woolley and Shaw (1962a) reported that 2-5-di¬
methyl serotonin was a potent antagonist of the
action of 5-hydroxytryptamine on the isolated rat
uterus and on dog blood pressure and that 2-5-di-
methyl bufotenine was slightly less potent (Woolley
and Shaw, 1956a). Substitution in the 2-position
yielded antagonists but substitution in Imposition
gave 5-hydroxytryptaralne-like substances. 1-benzyl-
2,5-dimethyl 5-hydroxytryptamlne (BAS) was the most
active antagonist, when tested in doses of 1 mg/Kg.
in dogs against the pressor action of 5-hydroxy¬
tryptamine (Shaw and Woolley, 1956a), Woolley and
Shaw (1956) suggested that 5-hydroxytryptamine
might be associated with the cause of the essential
hypertension and that BAS would be of therapeutic
use in such a condition, Wilkins (1956) reported
that the beneficial effects of BAS were similar to
those of reserpine in 25 hypertensive patients.
Wilkins and Hollander (1957) found that BAS alone,
or in combination with other drugs, reduced the
blood pressure of about 25^ of patients suffering
from hypertension. They were not sure whether
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this effect was due to the antagonism of 5-hydroxy-
tryptamine or not.
Quadbeck and H&hn (1954) prepared and studied
a series of 31 substituted gramine and tryptamine
derivatives. 5-fluoro, 5-ehloro, 5-methoxy, 5-methyl
and 5-brorao tryptamine were more or less active
synergists on isolated guinea pig colon. While 5-
fluoro, 5-methyl and 5-chloro tryptophan were antag¬
onists of 5-hydroxytryptamine. There was a marked
increase in the antagonistic potency when the di-
methylamino group was introduced into the 3-position
and an even greater one when introduced into the
5-position. The most active compound was 2-methy1-
5-chlorogramine.
Erspamer (1955) tested 9 gramine derivatives
against the effect of 5-hydroxytryptamine on the rat
uterus, and compared their activity with 3 repres¬
entative amino indoles of Woolley and Shaw. 2-methyl-
5-amino gramine was the most active and 2-methyl-5-
bromo gramine was the least. These active gramines.
in vitro., had negligible effect when tested in vivo
for antidiuretic activity. Erspamer suggested
that these drugs may be rapidly destroyed in the
body,
Gaddam, Hameed, Hathway and Stephens (1955)
studied a number of synthetic indole compounds for
their ability to antagonise the effects of 5-
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hydroxytryptamine on the rat uterus, Methyl
indoles, methyl-3-indolylacetonitrites and carbazole
derivatives, were feeble antagonists of 5-hydroxy-
tryptamine. The most active of the compounds were
5- and 6- benzyloxygramine, the next active com¬
pound was N-diraethyl tryptamine (£), The effects
of benzyloxygramine compounds were like those of di
benamine and lysergic acid diethylamide, which
developed slowly and became irreversible. Eventu¬
ally, the blockade could not be overcome even by
enormous doses of 5-hydroxytryptamine. They called
this type of block — "unsurmountable'1„ They con¬
cluded from the study of compounds related to
tryptamine that antagonistic activity was increased
by: i) introduction ef two methyl groups on the
amino group in the side chain}
ii) introduction of a methyl group in the 2-
position of indole nucleus (this effect was
also noted by Woolley and Shaw (1953) in
another series of substituted indoles)}
iii) introduction of a benzyloxy group in the 5-
f-
position of indole nucleus of gramine.
(They did not study 5-benzyloxy-N-dimethyl trypta¬
mine (§2).
Woolley and Shaw (1957b) have prepared and
tested a number of 1,2,3,4-tetrahydrocarbazoles with
CH3-NR or -C - NHa in the 6-positlon. Most of
NR
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these analogues antagonised the effects of 5-
bydroxytryptamine on the rat uterus and carotid
artery rings. Two of the compounds (the dimethyl
amino methyl tetrahydrocarbazole and tetrahydro-
earbazole N-phenyl carboxamidine) proved quite
effective in preventing the pressor responses to
5-hydroxytryptamine, when given to dogs intravenous¬
ly, but were of no such effeet when fed by mouth.
Dogs and mice receiving a daily dose of 25 mg./kg,
of 9-benzyl-6-dimethylaminomethyl-l,2,3,4-tetra-
hydrocarbazole exhibited excitement within a few
days.
Gyeriaek (1955) and Gyermek, Lazar and Csak
(1956) investigated the antagonism of effects of 5-
hydroxytryptamine by chloropromazine, phenergan and
dipareol on the rat uterus and arterial pressure of
decapitated cats. They found that their antagon¬
istic potency ran parallel with their sedative
effect. Chloropromazine was the most active ant¬
agonist and diparcol the least active,
Berger, Campbell, Handley, ludwig and Lynes
(1957) noted that chloropromazine, reserpine and
benaetyzine antagonised the effects of 5-hydroxy-
tryptamine on the rat's colon but they also antag¬
onised the effects of acetylcholine as well.
Hiilippot and Dallemagne (1956) have shown
that 5-hydroxytryptamine re-establishes neuro-
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muscular transmission in cats blocked by tubocurar¬
in and suggested that tubocurarine might be an
antagonist of 5-hydroxytryptamine.
Stimulant analogues of 5-hvdroxytryptamine
(i) Tryptamine This substance was obtained
by the action of putrifying bacteria on tryptophan,
(Evins and Laidlaw, 1910), and was studied by Laid-
law (1912). He suggested that it acted on some
peripheral nervous structure probably a peripheral
neurone and observed the similarity between the
action of tryptamine and nicotine on cats1 uterus.
Tryptamin© was used as an eebolic (Akimoto, 1937)
under the name of rutamine. These results have be&n
confirmed by Reid (1951). Raymond Hamet (1941a)
observed that the pressor response of tryptamine was
reduced by yohimbine. Tryptamine and 5-hydroxy-
tryptamine have been shown to have similar stimulant
actions except that tryptamine failed to release
adrenaline from the adrenal medulla when injected
into the stump of the superior mesenteric artery
(Reid, 1952).
Woolley and Shaw (1952) suggested that in the
sheep's carotid artery rings 5-hydroxytryptamine
acted on receptors which were more "stable" than
those acted on by tryptamine. In experiments on
the blood pressure of anaesthetised dogs they
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obtained further evidence (Woolley and Shaw (1957c)
that 5-hydroxytryptamlne and tryptamine act on
separate receptors. Two substances, "BAS" and
"BAS Phenol" blocked the pressor effect of 5-
hydroxytryptamlne without affecting the responses
to tryptamine,
Gaddura (1953a) concluded that on the guinea
pig ileum tryptamine and 5-hydroxytryptamine acted
on the same receptors. The l,M" and rtD" receptors
of the guinea-pig ileum described by Gaddum and
Picarelli (1957, see also page 21) are both regarded
as tryptamine receptors.
Vane (1959) showed that on the rat fundus strip,
amine oxidase inhibitors (such as Marsilid) potentl*
ated the effects of tryptamine but not those of 5-
hydroxytryptamine or of other 5-hydroxy analogues
of tryptamine. He showed that suspensions of
finely ground rat fundus oxidised tryptamine and 5-
hydroxytryptamine. He suggested that, in the iso¬
lated preparation, the amine oxidase was unable to
inactivate 5-hydroxytiyptamlne but could inactivate
tryptamine, 5-methoxytryptamine and other analogues
lacking the 5-hydroxy group. He supposed that
tryptamine entered the cell (inside which the amine
oxidase was located) whereas 5-hydroxytryptamine
and other 5-hydroxy compounds could not do so because
of their polar hydroxy group.
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(ii) Tryptamlne derivatives. N-Methyl trypta-
mine (13) was found by Chen and Chen (1933) to be
less active than tryptamine in raising the blood
pressure of a decerebrate cat but more active than
I-dimethyl tryptamine (§). R-trimethyl tryptamlne
(the quaternary salt) was the most active, having
l/20 potency of adrenaline.
Seki (1929) synthesised a-methyl-tryptamine (11)
and found that it was as powerful a uterine stimu-
lant as tryptamine but weaker in its action on the
heart and Intestine.
Bufotenine (21), a substance found in the skin
glands of the toad bufo vulgaris (Fhisalix and
Bertrand, 1893) was shown by Wieland, Konz and Mit-
tasch (1934) to be N-dimethyl-5-hydroxytryptamine.
It was synthesised by Hoshino and Shtmodaira (1935)
and studied by Raymond-Hamet (1941b, 1942a, b and c]
and Brspamer (1946). The corresponding quaternary
hydroxide, clnobufotenine, was isolated from the
Chinese drug "Chan Su" and from secretion from
toad*s skin (Chen, Jensen and Chen, 1931).
According to Erspamer (1954), if the activity
of 5-hydroxytryptamlne on the rat uterus is taken
as one, then:- bufotenine (21) is l/lOthj
N-methyl 5-hydroxytryptamine 1/3 f
5-hydroxy 3-dibutylamino ethyl-
indole (2£) as l/lOOO;
5-methoxytryptamine (28) 1/4,•
tryptamine 1/100 f
N-methyltryptamine (3.3) 1/200 and
N-dimethyltryptamine(2) 1/200.
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Gaddum et al (1966) found that bufotenlne (21)
had l/l5th to l/40th the activity of 5-hydroxytryp-
tamine on the rat uterus. Cinobufotenine (26) was
l/lOth as active as 5-hydroxytryptamine on both the
rat uterus and guinea pig ileum and they suggested
that it acted on both 5-hydroxytryptamine and nico¬
tine receptors on the latter preparation. 5-Methyl<-
tryptamine (§0), a-methyltryptamine (;yL) and N-lso-
propyltryptamine were only 1/500 - l/l,500 times as
active on 5-hydroxytryp tamine on the rat uterus.
Ginobufotenine (26) was approximately one
half as active as 5-hydroxytryptamine and quali¬
tatively gave similar responses except in cats,
where it was usually pressor, whereas 5-hydroxy-
tryptamine was depressor (Page and McCubbln, 1953a)
The pressor effect of cinobufotenine (26) in dogs
was blocked by yohimbine (Raymond-Hamet, 1943). It
was l/20th to l/l00th times as active as 5-hydroxy-
tryptamine in its ability to stimulate the isolated
heart of a mollusc, venus mercenaria (Twarog and
Page, 1853), and is reported to be an inhibitor of
cholinesterase (Sobotka and Antopol, 1937).
Fabring and Hawkins (1956) reported that intra
venous injection in man of bufotenine (2§) caused
hallucinations and that in monkeys it and lysergic
acid diethylamide, produced a syndrome characterised
by gross sensory disorders without any marked defect
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In the muscular power (Ewart et al. 1955).
Szara (1956, 1957) has shown that M-dimethy1-
tryptamine (£) and diethyltryptamine (4) produce
psychic effects in man somewhat similar to that of
mescaline and lysergic acid diethylamide. A
striking difference between the effects of these
drugs and those of lysergic acid diethylamide is
that with ft-dimethyl- and N-diethyltryptamine (&,4)
the symptoms appear within 3-4 mins. of the inject¬
ion of the drug and pass away within 1 hr. whereas
the effects of lysergic acid diethylamide take 1-2
hrs. to develop. This may indicate a different
mechanism of action. Unlike lysergic acid diethyls
amide and mescaline, both the derivatives of trypta-
mine caused choreiform athetoid movements. This
phenomenon could be a new tool for investigating
experimentally the mechanism of extra-pyramidal com¬
pulsive movements. The psychic effects of trypta-
mine derivatives supports the idea that Schizo¬
phrenia may be the result of an abnormal indole
metabolism of the body.
According to Brspamer (1964) tryptamine is con*
verted in the body into indole acetic acid (in mod¬
erate amounts) and indole aceturic acid (in large
amounts), 5-Methoxytryptamine (28) yields 5-meth-
oxyindole acetic acid and K-dimethyltryptamine (2)
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yields small amounts of indole acetic acid and mod¬
erate amounts of indole aceturic acid, Szara (195$)
found that the main metabolite of IT-dimethyl trypta-
mine (£) is 3-lndole acetic acid.
Conclusion
From what has been described it will be seen
that the mode of action of 5-hydroxytryptamine and
of its antagonists in the body, is complicated and
not yet fully understood. It is, at any rate,
certain that 5-hydroxytryptamine has some important
function in the body. The properties of analogues
of 5-hydroxytryptaaine will depend on whether these
drugs act like 5-hydroxytryptamine or antagonise it,
and also on their ability to cross the blood brain
barrier and their susceptibility to attack by such
enzymes as amine oxidase. Although it is not poss¬
ible to predict what substances might have particular
effects, there is, nevertheless, a reasonable expec¬
tation of finding interesting compounds amongst ana¬
logues of 5-hydroxytryptamine.
This thesis describes the actions of substances
(many of these new) which modify the actions of 5-
hydroxytryptamine. The chief object of this work
was to find a potent antagonist of 5-hydroxytrypta-
47
mine but tests were not restricted simply to ant¬
agonistic activity and an attempt has been made to







It was originally hoped that the compounds
would he antagonists of 5-hydroxytryptamine and it
was, therefore, expected that tests of antagonistic
activity would be done on the rat uterus in the
manner described by Gaddum, Hameed, Hathway and
Stephens (1956). The first experiments, however,
showed that most of the compounds, even those which
antagonised 5-hydroxytryptamine, would themselves
cause contractions. It was therefore necessary to
evolve a quantitative method for determining the
stimulant activity. It was planned to use the
guinea pig ileum in addition to the rat uterus for
determining antagonistic or stimulant properties,
but it was first necessary to show that Gaddum and
Picarelli's (1957) classification of the tryptamine
receptors in the guinea pig ileum into "M' and "D"
really applied to tryptamine as well as to 6-hydroxy-
tryptamine (see p. JP-Y This led to a study of the
effects of drugs on the responses of the guinea pig
Ileum to tryptamine and 5-hydroxytryptaraine. Some
quantitative work was done on the activity of the
compounds on the guinea pig ileum, both as antagon¬
ists and as stimulants, but the rat fundus strip,
which had ^ust been introduced by Vane (1957),
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appeared to be more likely to give reliable infor¬
mation, so systematic testing was done on this
preparation. The quantitative methods on all these
tissues were essentially the same. Some qualitat¬
ive work was also done on the perfused rabbit's ear
and even here the procedure was similar in principle
to the qualitative experiments done on the rat uter¬
us, guinea pig ileum and rat fundus strip.
The experimental section is, therefore, divi¬
ded into: 1) Description of the preparations.






d) Special procedures for the
guinea-pig ileum.
e) Special procedures for the
perfused rabbit ear.
1) Preparations
The Isolated rat's uterus in oestrus: This
tissue was used by Erapamer (1940) for the assay of
enteramine (5-hydroxytryptamine) in tissue extracts.
In order to increase the sensitivity, Erspamer
(1942, 1962) subsequently used ovariectomised rats
'
brought into oestrus by injection of oestradiol,
Amin, Crawford and Gaddum (1954) simplified the
technique by using normal virgin rats (160-2OOg.wt.)
in which the uterus had been brought into oestrus
50
by subcutaneous injection of 10 pg. of stilboestrol
in 0,1 ml, of arachis oil per 100 g. body weight,
the day before the experiment.
Technique t The procedure followed was that
of Ainin, Crawford and Gaddum (1954), The animal
was killed by a blow on the head and both horns of
the uterus were dissected out from the adipose
tissue and cut into two (making four pieces in all),,
One piece was used at a time and the rest could be
stored in the refrigerator at 4°C for up to 2 days
without losing any sensitivity for 5-hydroxytrypta-
mine. The tissue was suspended in De Jalon solu¬
tion1 in a 2 ml. bath. One end was fixed and the
other tied to a frontal writing lever. The bath
temperature was kept at 30°C and compressed air was
bubbled through the solution in the bath. The con¬
tractions were recorded on a smoked drum with the
lever having Ii8 magnification, and the tension on
the preparation was 500-750 mg. The tissue was
allowed to relax for about 30 min, before any drugs
were added. There was a tendency for the responses
to be almost all or none with 5-hydroxytryptamine,
Composition of De Jalon Solution recommended
by Gaddum, Peart and Vogt (1949) in gram/litre
NaCl»9| KC1,0.42j CaCla,0.06f NaHC03,0.5j
Glucose, 0.5.
51
i.e. the dose response curve was very steep. Inc¬
reasing the tension on the tissue and/or increasing
the magnification of the lever seemed to decrease
the slope of the dose response curve. Doses of th£
order of 5-20 ng. 5-hydroxytryptamine and 1-5 ^.g.
tryptamine usually produced good contractions.
With both the drugs there was a latent period
of 15-20 seconds before the start of the contraction
and another 30 sec, before it was complete. The
bath was then emptied and refilled twice and the
muscle then rapidly relaxed (unlike the rat fundus
Cp» 53). ^ke tissue did not usually show tachy¬
phylaxis to 5-hydroxytryptamine and tryptamine, but
to exclude this phenomenon a small dose of 5-hydroxy¬
tryptamine was applied frequently in between the dif¬
ferent doses of the stimulant drugs. If the response
to this dose was depressed, it was important to wait
till it recovered before the assay was continued.
The isolated rat fundus strip preparation was
described by Vane (1957) who used it for the assay
of 5-hydroxytryptamine. He considered it robust
and showed that the sensitivity to 5-hydroxytrypta¬
mine was 10-100 times more than that of the rat
uterus in oestrus. Vane (1959) modified his origi+
nal technique by recording movements of the muscle,
not with a spring lever, but with a pendular auxo-
tonic lever (Paton, 1957).
Figure IX
Diagrammatic representation of the rat fundus strip preparation.
1. Stomach as a whole. The arrow is pointing at the cut made
in the pyloric part. 2. Isolated fundus along with a thin
rim of pyloris. Arrow is pointing at the incision to be made
along the lesser curvature to cut open the fundus. &. The
fundus cut open by multiple incisions, 4. The fundus strip
tied and pulled out. The bits of the pyloric tissue are to be
trimmed off. 5. The long bath holding the tissue and the tube
supplying oxygen. <3. Auxotonic pendular lever (Paton, 1957
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Technique t A rat of 250-400 g. was killed
by a blow on the head and the fundus of the stomach
removed. (There is a clear dividing line between
the white fundus part and the pink pyloric part).
It was washed with tyrode1 solution and cut into a
long strip exactly as described by Vane (Fig. II).
The strip was suspended in tyrode solution at 37°C
in a long narrow bath of 8 mm. diameter and 15 cm.
lengthj the tissue was fixed at one end to the
tube supplying oxygen and the other end attached to
the lever. normally there was a steady flow of
tyrode 60 drops/rain, through the bath (overflowing
at the top). Before the drug was added to the
bath, the flow was stopped. When the contraction
was completed, the flow was re-started at a rapid
rate (about 2.5 ml./sec.) for 10-15 seconds to wash
the drug out? it was then reduced to the original
rate. The movements of the muscle were recorded
with a calibrated pendular auxotonic lever (Paton,
1957) made of balsa wood with a frontal writing
point on a smoked drum.
In some preliminary experiments the lever,
like that used by Vane, had a magnification of 1j16
and the load on the muscle was 1 gram. In order
Composition of tyrode solution in gram/litre:
NaCl,0.8j CaCl3,0.02j KCl,0.02j MgCl3,0.01}
WaHarO^jO,005{ NaHC03,0.1| Glucose, 0.1.
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to plot the entire dose/response curve with the
stimulant compounds, only three-quarters of the
length of the dissected tissue was used? the
magnification of the lever was reduced to 1j4 and
the load on the muscle was 0.5 gram. The tissue
was allowed to relax for about 45 min. before the
start of the experiment. The drugs were added to
the bath with a syringe in a volume not exceeding
0.2 ml. The tissue was stretched after each con¬
traction with 5-hydroxytryptaraine and tryptamine
for a period of 60 sec. by bringing down the lever
to a fixed level just below the normal base line.
Such treatment did not disturb the regularity of
the base line. Air was bubbled through a test
tube holding water which was attached to the bar
supporting the lever. It caused sufficient vibra¬
tion to prevent the writing point sticking. Hyos-
cine hydrobromide was added to the tyrode solution
in a concentration of 100 ng./ml. as a routine,
except when atropine-like drugs were investigated
(p.120). This drug reduces any acetylcholine-like
effects of the compounds, and also the irregularity
of the base line. The contractions caused by 5-
hydroxytryptamine were complete in about SO sec.
and the preparation was then washed for 10-15 sec.
and, starting at the same time, stretched for about
60 sec, A further 2h min. were allowed for the
recovery with a complete cycle of 5 minutes.
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The isolated guinea pig Ileum: The action of
b-hydroxytryptamine on this tissue has been studied
by Robertson (1953), Rocha e Silva, Valle and Pica-
relli (3.953)} Gaddum (1953a) and Gaddum, Hameed and
Hathway and Stephens (1955). The preparation has
been used for the assay of 5-hydroxytryptamine and
for the study of drugs which modify the action of
o-hydroxytryptamine. Gaddum and Picarelli (1957)
devised a technique for investigating the effects of
different drugs on the " D" and "M1 type of 5-hydroxy^
bryptamine receptors (p.21). When a concentration
Cf 1 pg,/ml, morphine is maintained in the bath, the
" M" receptors appear to be more or less completely
blocked, and any additional antagonistic effect of
n drug is then thought to be due to an action on the
11D" receptors. When the intestine is exposed to a
Concentration of 0.1 p,g./ml, dibenzyline for 30 min,
the "DH receptors appear to be more or less complete*-
ly and permanently blocked and any additional effect
is then thought to be on the "M" receptors.
When investigating the effect of drugs on the
guinea pig ileum, it is, therefore, usual to use the
preparation treated with morphine (for the action on
"DM receptors) or the one treated with dibenzyline
( for the action on "M" receptors).
5£
Technique: Guinea pigs weighing 150-260 g.
which had been deprived of food over-night, were
killed by a blow on the neck and by cutting the
throat. The portion of ileum nearest to the ileo-
caecal junction was removed and cleaned with tyrode
solution, introduced into the lumen by a pipette if
necessary. A 2 cm. piece of gut was tied at both
ends with cotton and suspended in a 2 ml. bath in
tyrode solution at 3?°C. Compressed air was
bubbled through this bath at a moderate speed. The
movements of the gut were recorded with a light
frontal writing lever with ls5 magnification on a
smoked drum.
The dose of 5-hydroxytryptamine used was in
the range of 10-100 ng. and of tryptamine in the
range of 1-10 p,g, In order to obtain a quiet and
sensitive preparation, it is important to avoid un¬
necessary trauma to the tissue. If the tissue
were left in tyrode solution at room temperature for
more than 1 hour, its sensitivity decreased. 5-
hydroxytryptamine and tryptamine contractions were
completed within 30-45 sec. and after being washed
twice the preparation relaxed rapidly. In order to
avoid interference from tachyphylaxis, a small dose
of 5-hydroxytryptamine was applied in between the
different stimulant doses and the experiment was
continued only when these responses were normal.
The drugs were added in a volume of up to 0.2 ml.
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to the hath, and the cycle of events took 4 minutes
In the study of drugs on the "D'1 and "M" recep¬
tors, the technique used was that of Gaddum and
Picarelll (1957), Morphine in a concentration of
3,5 x 10 M was added to the tyrode solution, so
that the tissue was constantly exposed to the action
of morphine, when drugs were to be tested on the "D"
receptors. Similarly, when used for investigating
the effect of drugs on the "M" receptors, the tissue
_7
was exposed to 3,4 x 10- M dibenzyline for 30 min.
at the beginning of the experiment, alternatively
lysergic acid diethylamide was added to the tyrode
__ 8
solution in a concentration of 3 x 10 M,
In the presence of morphine, small responses
were produced by about 10 ng. 5-hydroxytryptamine or
1 |ig. tryptaminej maximum responses were produced
by 100 ng. 5-hydroxytryptamine or 10 p,g. tryptamine,
After the ileum had been treated with dibenzyline
small responses were produced by about 500 ng, 5-
hydroxytryptamine and maximal responses by 4 p,g.5-
hydroxytryptamine. A 200 jig, dose of tryptamine
only produced a threshold response. When lysergic
acid diethylamide was maintained in the tyrode solu¬
tion, contractions were caused by doses of between
200 ng. and 2 jig. 5-hydroxytryptamine and by between
10 p.g. and 200 ng. tryptamine.
Responses to 5-hydroxytryptamine and tryptamine
on the guinea pig ileum in the presence of morphine
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and lysergic acid diethylamide, and after treatment
with dibenzyllne, appeared to be the same as in the
normal guinea pig ileum, in that the contractions
were completed within 30-45 sec. of the application
of the drug, and there was a rapid relaxation after
washing out the 5-hydroxytryptamine and tryptamine.
The time interval between the application of the
different stimulant drugs was still maintained at
4 minutes. A dose of 5-bydroxytryptamine causing
a small contraction was added at intervals to de¬
tect tachyphylaxis.
The perfused rabbit's ear? This tissue was
used by Rapport, Green and Page (1948) for the
study of serotonin, and also studied by Fingl and
Gaddum (1953), Gaddum and Hameed (1954)» Garven
(1955) and Savini (1956).
Techniquet A rabbit, preferably with large
veins in the ears, was killed by a blow on the head,
care being taken to avoid injury to the ears. Both
ears were cut off as close to the skull as possible.
The central artery, vein and nerve lying on the pos¬
terior aspect of the pinna near its thinner margin
were dissected out. The skin overlying these
vessels was slit longitudinally to get a good view.
A thread was tied round the tip of the artery, whic
looks whiter than the vein. A small polythene
cannula was inserted into the artery. Some Green
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and Page solution1 was cautiously injected through
the cannula with a syringe. If the procedure so
far were correct, blood-coloured fluid should come
out of the main vein lying near the cannulated
artery. The polythene cannula was fitted to a
Gaddum and Kwiatkowskl* s (1938) rubber-capped in¬
jection cannula and was connected to the perfusion
reservoir containing Green and Page solution. The
ear was placed on a draining plate and fixed with a
pin. The perfusate coming out of the cut veins
was collected in a funnel which ended in a horizon¬
tal capillary tube. The capillary end of the coll
ecting funnel was then attached to a drop timer
(Gaddum and Xwiatkowski, 1838). The reservoir
containing Green and Page solution had a capacity
of 2 1. and was kept at a distance of about 12 in.
from the level of the pinna, in these circumstances
the flow through the ear should be 60-70 drops/min.
The tube connecting the reservoir to the injection
cannula must be left without any obstruction, to
avoid any intervention by a second constriction in
the passage of the solution. The reservoir should
not be raised (to increase the flow) more than a
few inches at a time or the tissue may become per¬
manently damaged. The fluid was allowed to flow
through the ear for a few minutes till the perfus¬
ate was clear. The ear was then removed (together
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with the cannula attached to its artery) and kept
in normal saline at 4°C over-night. The tissue was
very sensitive the next day and could be used con¬
tinuously until the third day. When the switch of
the drop recorder was at "make", the time the drop
took to stay in between the two electrodes corres¬
ponded with the vertical height of the record of
the drum.
The drugs were injected through the injection
cap into the air space very slowly, to avoid alter¬
ing the pressure of the perfusion fluid. The int¬
erval between the application of different stimulant
drugs depended on the degree of vasoconstriction
produced. An interval of 3-10 min. was sufficient
between the different doses which produced moderate
responses. The drugs were injected up to a final
volume of 0.1 ml. When a large dose of the stimu¬
lant drug was given and the resultant vasoconstric¬
tion was severe, the recovery could be hastened by
raising the reservoir by a few inches for a short
time. Convenient doses (which produced moderate
effects) were 0.5-1 ng. 5-hydroxytryptamine, 5-10
ng. tryptamine and 2.5-5 ng. adrenaline.
2. Methods
a) General qualitative procedurest The pur¬
pose of this type of experiment was to find out in a
qualitative manner what the drugs did, A few
6(1
responses to 5-hydroxytryptainine were obtained and
a suitable dose giving a small response was selected
about 6 ng. in the rat uterus and rat fundus strip.
This was given at regular intervals throughout the
experiment. The test drug was applied to the tissue
?
in a low concentration (about 10 M on the rat uter¬
us and fundus) and washed twice (after 45 sec. on
the rat uterus and after 90 sec. on the rat fundus),
The selected dose of 5-hydroxytryptamine was then
given to see if the test drug had any effect, such
as antagonism or synergism. If the response to the
selected dose of 6-hydroxytryptamine were altered,
the dose was repeated at the usual interval (with
washing) until the response returned to normal. The
test drug was then again applied, but in 10 times
the previous concentration, and the experiment con¬
tinued. The highest concentrations tested were
10 to 10 M. In some experiments with very high
concentrations, the drugs were left to act for 10-
16 minutes.
b) Quantitative determination of antagonistic
activity:
i. Determination of the dose ratio: The dose
of 6-hydroxytryptamine (or tryptamine or acetylcho¬
line) which caused about 50^ of the maximum response
was found} to do this it was usually necessary to
apply two or three different doses of 6-hydroxytryp-
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tamlne In order to obtain some idea of the dose res¬
ponse curve, After this, the antagonist was main¬
tained in the bath for a particular period (usually
1 hr.) and the dose of 5-hydroxytryptaiaine (or tryp-
taaiine or acetylcholine) which caused 50% of the
maximum response was again determined. The ratio of
the two concentrations, after and before the action
of the antagonist, is the dose ratio for that par¬
ticular concentration of antagonist applied for that
particular time. In some oases the experiment was
continued, arid the recovery of the tissue observed
after the antagonist was removed, (On the rat
uterus, it was possible to add the antagonist dir¬
ectly to the bath, but on the rat fundus strip the
antagonist had to be added to the reservoir contain¬
ing tyrode solution, which flowed over the prepara¬
tion), As the dose ratio varies with the concen¬
tration, it can only be used to eompare the antagon¬
istic activity of substances which are active at
similar' concentrations. In order to assess with
any accuracy the relative potency of substances
which differ in activity to any extent, it is necess
ary to use the drug ratio described below.
ii. Determination of the drug ratios A few
doses of the stimulant drug (always 5-hydroxytrypta
mine) were given, in order to find the doses which
cause a maximum response and 50% of the maximum
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response.
The antagonist was maintained in the bath in a
suitable concentration, previously determined by the
dose ratio experiments. When the antagonist was
present, more agonist was required in order to pro¬
duce a response 50^ of the maximum, and at the end
of 1 hr. the concentration of stimulant which pro¬
duced 50% of the maximum response of the tissue was
determined. The drug ratio was obtained by divi¬
ding this concentration by the concentration of the
antagonist. It should be independent of the con¬
centration of the antagonist, because if there is
more antagonist present, more stimulant drag will
be required. The drug ratio is, therefore, a con¬
venient measure of antagonistic activity. In point
of feet, with many drugs the block produced by higher
concentrations could not be overcome by increasing
the concentration of the stimulant drug. This form
of irreversible block has been referred to as
"unsurmountable" (Gaddum, Hameed, Hathway and Ste¬
phens , 1955).
To check that the antagonism is specifically
against 5-hydroxytryptamine, control contractions,
usually with acetylcholine, were obtained before
and after the antagonist was given, Gaddum,
Hameed, Hathway and Stephens (1955) have stated
that this method is unlikely to give reliable
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results when the dose ratio is small, and the con¬
centration of the antagonist should therefore be
always high enough to produce a dose ratio of at
least 5 and generally much more. (hi the rat uteru$
antagonist activity was measured by means of the
drug ratio whenever possible but on the rat fundus
strip this was not done even when the dose ratios
were more than 5. The production of a maximal
response on the rat fundus, which is essential for
determining the drug ratio, would render the tissue
insensitive for a considerable time afterwards,
PAa values (Gaddum, Hameed, Hathway and Steph¬
ens, 1955) of the antagonists were not determined
because the activity of the compounds was not very
high.
c) Quantitative determination of stimulant
activity t The log. dose/response curves of 6-
hydroxytryptamine and one of the stimulant compounds
were compared on one tissue. These curves (Fig.
were plotted and examined with the naked eye to see
if they were parallel. If they were, it was poss¬
ible by measuring the distance between the two line$,
to determine the equipotent molar ratio of the test
compound, that is, the number of molecules of the
drug required to produce the same effect as that of
one molecule of 5-hydroxytryptamlne (Table I). A
high figure indicates a low potency.
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In these experiments, it was necessary with
some of the compounds to modify the cycle of events.
On the rat uterus it was a long time before the
effects of certain compounds wore off, and the con¬
trol response with the small test dose of 5-hydroxy-
tryptamine returned to normal. On the rat fundus,
it was sometimes necessary to allow up to 3 min. for
the contraction to reach its maximum, and also to
allow even up to 45 min, stretching to assist recov»-
ery. If insufficient time was allowed for recovery,
i.e. for the base line to return to normal and the
control response to 5-hydroxytryptamine to recover,
the responses to the test drug were reduced and the
dose response curves consequently appeared to
flatten out. This gave a misleading impression in
the earlier part of the work, that these compounds
were partial agonists (Stephenson, 1956). Later
on, substances were found which genuinely showed
characteristic flattening out of their dose res¬
ponse curves below the top. This occurred even
though the control responses to 5-hydroxytryptamine
indicated that the preparation had been allowed
sufficient time for recovery.
In stimulant experiments on the rat fundus it
was necessary to reduce the magnification of the
lever to 1-4 (see p.53), in order to record the
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maximum responses. Because of the persistence of
the effects of high doses, the doses were given in
increasing order of magnitude, rather than in any
random order. After many of the compounds, the rat
uterus only returned to normal very slowly, and the
determination of their dose/response curves became
very tedious, particularly with high doses, With
such compounds, simple matching experiments were
performed and the equipotent mclar ratios calculated
by comparing the doses of 5-hydroxytryptamine and
the test dxug which produced roughly 50% of the
maximum contraction (these are indicated by ttK" in
Table I) „
d) Special procedures for the guinea sia ileum.
It was first necessary to compare the dose
ratios of a number of standard antagonists against
5-hydroxytryptamine with the dose ratios against
tryptamine. The antagonists used were lysergic
acid diethylamide and morphine, in concentrations
identical with those used by Gaddurn and Picarelli
(1957), Acetylcholine and nicotine were used as
control drugs. Although it was not necessary in
determining the dose ratio to plot the complete
dose response curve for 5-hydroxytryptamine and
tryptamine, this was, nevertheless, dene both before
and after the action of lysergic acid diethylamide
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The results (which are discussed on p. 95
indicated that Gaddum and Picarelli*s (1957) assump¬
tions were Justified, and this preparation was there
fore used for testing both antagonistic and stimu¬
lant activity of a number of the compounds. Exactly
the same procedure was used as in the experiments
on the rat uterus and the rat fundus strip, except
that the tyrode solution contained a concentration
_6
of either morphine (3,5 x 10 M) or lysergic acid
_8
diethylamide (3 x 10" M). Experiments were also
done on the preparation treated with dibenzyline.
In these, the tissue was exposed to a concentration,
7
of dibenzyline (3.4 x 10" M) for half-an-hour. The
preparation was then washed and used with normal
tyrode. After this treatment with dibenzyline,
regular responses could only be obtained with 5-
hydroxytryptamine for about 2 hr. and in any experif-
ment it was only possible to compare the stimulant
properties of one compound with those of 5-hydroxy-
tryptamine. The other two preparations (in the
presence of lysergic acid diethylamide and morphine)
were, however, strong enough to allow more than one
such comparison between 5-hydroxytryptamine and an
analogue.
e) Special procedures for the perfused rabbit
ear: If the general qualitative procedure showed
that a compound antagonised the effects of 5-hydrox-
ytryptamine on this preparation, the following pro-
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cedure was adopted. Equivalent responses were ob¬
tained with 5-hydroxytryptamine and adrenaline. A
dose of the compound which was expected to antagoni$e
5-hydroxytryptamine (from the qualitative experi¬
ment) , was given and followed by the original doses
of 5-hydroxytryptamine, tryptamine and adrenaline.
If there was antagonism, the doses of the stimulant
drugs were increased in order to obtain the dose
ratio, but the dose of the antagonist was not re¬
peated and thus the antagonism gradually wore off.
The stimulant activity on this preparation was
determined in the usual way, by plotting the dose
response curves from the compounds, 5-hydroxytryp¬
tamine and tryptamine. This tissue could be used
for many comparisons during the day, but the range
of concentrations is very limited, because it is
very easy to produce the maximum vasoconstriction
by merely doubling the dose. Drugs which had no
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-CHa-CHa~NH( CH3) HCl
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30°C Expt strip 37°C Expt
26 5-OH -CHs-CH3NMeaI Iodide
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>20,000 2 >10,000 2
27 5-OH -CHa-CH3lMe2Et1I Iodide
360 > 20,000 2 >10,000 2
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330.5 >20,000 2 J 4
33 5-0C7H7 -CHg-CHgNEtg HC1
358.8
>10,000 1 1r 4701 60 4
34 5-0C7H7 -CHa-CHsNaPrs HC1
386.5 >20.000 1 1[* 8671183 2
35 5- 0C 7H7 -CH2-CH2N£soPr2 HC1
386.5 >10,000 1 1f* 6141 80 3
36 5-OC7H7 -CHa-GHaNnBua HC1
414.8 20,000
1 20,000 1
37 5— 0C 7H7 -CHa-CHaN ^0 HC1
372.7 >20,000 1 >5,000 1
38
(S) 5-0C7H7 -CH -CH( OH ) NH*3 3 3 HC1317.5 20,000 1 1["63 ± 11 2
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30°C Expt strip 37°C Expt
39 5-0C7H7 -CII^HaNMe3I Iodide
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,>10,000 2 5,000 2
40 5-OC7H7 -CH3-CHaHHe3StI Iodide
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(¥oolley and Shaw's BAS)
HC1
375.5 ^ 20,000 2
t Indicates the dose/response curve was not parallelto that of 6-hydroxytryptamine, at the top.
(M) indicates that estimates were determined by
matching (see text).
The explanation of ( S), (C), (Cu), (V) and (W) are
given in the acknowledgments.
OsaaJtUU)
Isolated rat uterus preparation
Synergism between 5-hydroxytryptamine (HT) and N-dibutyl-
tryptamine (nBua). N-dibutyltryptamine (4.8 x 10-6M) by itself
had no effect on the tissue but when added with 2 ng, of HT, the
response was about as big as that of 4 ng. of HTy previously.
Time in minutes.
Figure III CM




HT HT HT HT HT
8 8 20 20 40
ng ng ng ng ng
nEt2 4 x 10 M
Antagonism of 5-hydroxytryptamine (HT). Responses are
shown by HT (8, 10, 20 and 40 ng,) before and after maintaining
4 x 10- M concentration cf N-dlethyltryptamine (nBt3) as indicated.
After 18 sain, 40 ng, of HT produced a response equivalent to 10 ng.
of HT, previously giving a dose ratio of 4.
U).
Isolated rat uterus preparation
HT HT iPr2 7Pr.
10 5 3-5 7
n9 ng nM n M
Stimulant action of diisopropyltryptamine (iPr2). 5-Hydroxy-
tryptamine (HT) 5 and 10 ng, gave comparable responses to 3.5 and
7 n, Moles of the analogue.
10 ng. of HT = 5.5 p Moles.
Time in min.
Figure III (d)
Isolated rat uterus preparation
Repeated contractions caused by N-dipropyltryptaiaine (nPra).
The analogue, in concentration of 10-was maintained in the~bath
for 4 min. The repeated contractions persisted in spite of




Isolated rat uterus preparation
Cc HT HI HTnP^ HT Cc HT
-4
500 3 5 5 3*6x10 5 500 200
M
ng ng ng ng ng ng ng
V >
nPr*2 7-2 x 10 4M
Profound depression.
Responses to carbachol (Cc 500 ng) and 5-hydroxytryptamine
(HT 3» 5 and 200 ng,) are shown before and after |reatment of the
tissue with dipropyltryptamine (3,6 and 7.2 x 10" M), After add*
ing the analogue in a concentration of 7,2 x 10- M, the base line
suddenly became steady and both Cc and HT were blocked.
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RESULTS
1. EFFECTS OH THE ISOLATED RAT UTERUS
Introduction. The qualitative experiments showed
that the effects varied with the concentrations as
well as with the nature of the drug. It was found
that a few compounds (&, 2£, 32-38) would antagonise
the effects of 5-hydroxytryptamine, hut some of
these, (g, when given in higher concentrations,
themselves caused contractions of the preparation.
Nearly all the remaining compounds caused contract¬
ions without antagonising 5-hydroxytryptamine in
lower concentrations. Still higher concentrations
-6
(10* M) of any of the compounds which could stimu¬
late the preparation (including those which antagon*
ised S-hydroxytryptamine in lower concentrations
caused repeated contractions, and in even higher
concentrations caused profound depression in which
the tissue failed to respond even to acetylcholine.
Fig,III illustrates all these different types of
effect which are divided into:
(I) Synergism with 5-hydroxytryptamine, tryp-
tamine and acetylcholine,
(ii) Antagonism to 6-hydroxytryptamine and
tryptamine.
(iii) Stimulant action.
(iv) Production of repeated contractions,
(v) Profound depression,
(i) Synergism. It was thought that the com¬
pounds might potentiate the actions of 5-hydroxy-
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tryptamine, so responses were obtained with these
two drugs, and with acetylcholine. The preparation
was then treated for up to 30 minutes, with the test
drug in a concentration so low that it did not cause
contraction. Responses were again obtained with 5-
hydroxytryptamine, tryptamine and acetylcholine. All
these were often bigger than the original responses
but were never as much as the responses to twice the
original dose. This phenomenon did not seem to be
potentiation similar to the ten- or more fold inc¬
rease in acetylcholine responses produced by eser-
ine. It was referred to as 1synergism*. It
seemed possible that it might be a form of simple
addition, particularly because the dose response
curve of 5-hydroxytryptamine in this preparation is
very steep. For example, in a particular prepar¬
ation, although 4 ng. 5-hydroxytryptamine produced
a reasonable contraction, 2 ng, 5-hydroxytryptamine
had no apparent effect. The addition of 2 ng. 5-
hydroxytryptamine to a preparation which had alreadjr
been given 2 ng. 5-hydroxytryptamine (without appar¬
ent effect) might result in a contraction equivalent
to that produced by 4 ng. Figjla shows an experi-
ment in which a low dose (4,8 x 10 M) of N-dibutyl-
tryptamine (7) was given; this, by itself, had no
effect, but when 2 ng, 5-hydroxytryptamine was
Isolated rat uterus -preparation
Responses to 5-hydroxytryptamine (HT 5 and 10 ng,),
tryptamine (T, 1 and 2 p,g.) and acetylcholine (Ach, 100 and 200 ng.)
before, during and after maintenance of 5-hydroxytryptamine (1.25 x
10" ) in the bath. This shows the synergism of all the three drugs
with the small background dose of 5-hydroxytryptamine.
Time in min.
FIGURE V
Isolated rat uterus preparation
HT Aeh HT HT Ach HT Ach HT HT Ach HT Ach
10 200 5ng 10 200 20 400 10ng 20 400 40 800
ng ng A+h ng ng ng ng +ch ng ng ng ng
lOOng 20Cfcg
Synergism between acetylcholine (Ach) and 5-hydroxy-
tryptaraine (HT). The responses to a combined dose of 5 ng of 8HT
plus 100 ng. of Ach is not significantly greater than that of 10 ng.
of SHT or to 200 ng. of Ach. alone. Similarly, the response to a
combined dose of 10 ng, of 5HT plus 200 ng, of Ach, is not signifi¬
cantly greater than that of 20 ng. of 5HT or to 400 ng, of Ach,
Time in min.
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added as well, there was a response as great as
that to 4 ng. £-hydroxytryptaralne previously. It
was found that this effeet was shown only by the
purely stimulant compounds over a limited range of
concentrations - because a fivefold increase was
usually adequate for the transition from no effect
at all to stimulation of the preparation. It was
further possible to produce similar results with 5-
hydroxytryptamine itself (Fig.IV) or with acetyl-
7
choline (5 x 10" ).
Further evidence that the effect of this low
concentration of acetylcholine on 5-hydroxytrypta-
mine and tryptamine was merely an addition, was
obtained by the following experiment. A contraction
was obtained with a dose of 6-hydroxytryptamine
(10 ng, in a 2 ml, bath) and a comparable contraction
with acetylcholine (200 ng.). When half the dose
(5 ng,) of 5-hydroxytryptamine was added at the same
time at half the dose (100 ng.) of acetylcholine,
the contraction produced was slightly, but not sig¬
nificantly, bigger than those obtained previously
(Fig, V). This experiment was repeated, using
twice the doses, with the same result, and also with




Antagonistic activity on the rat uterus












































































































Indicates potentiation which was more marked at the end of 1 hr.
After washing, this effect passed off much more quickly than did
the antagonism to 5-hydroxytryptamine,
- Signifies not tested
(All the antagonists were kept in the bath for 1 hr.)
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(ii) Antagonism of 5-hydroxytrvptarnine and
tryptamine: This was only shown by those com¬
pounds listed in Tables II, III and IV, which summar¬
ise the results of quantitative experiments on the
antagonistic properties of the compounds on this
preparation. The antagonism took about 1 lir. to
reach a maximum, and the same time to wear off.
Gaddum, Hameed, Iiathway and Stephens (1955) obtained
drug ratios of 0.66 for 5-benzyloxygraralne (41) and
0.027 for K-dimethyltryptamine (j3)(§ calculated on
a molar basis) which agree quite well with these
results.
In all the experiments, whether the drug ratio
or dose ratio, control responses to acetylcholine
were not suppressed. 5-Hydroxy<*H-dibutyltryptamine
(25) and 2-methyl H-dimethyltryptamine (16) actually
left the tissue more sensitive to the effects of
acetylcholine. It will be seen from Table III that,
when the antagonists were present in high concen¬
trations, the responses to 5-hydroxytryptamine did
not increase as the concentration of 5-hydroxy~
tryptamine was increased, and this gave a very high
and unreliable value for drug ratio. This situ¬
ation has been described by!Gaddum,Hameed, Hathway
and Stephens (1955) as an "unsurmountable block".
High concentrations of some of the compounds
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TABLE 3























































































3 N-Dimethyltryptamine 99,0 0.042 * 0.014 4
^Indicates that at the high concentration, the block became unsur-
mountable as previously shown by Gaddum, Hameed, Hathway and
Stephens (1955) using 5-benzyloxygramine.
Ffrfflire VI
Isolated rat uterus preparation
HT T T Ach HT T Ach HT T Ach Ach HT T
10 1 2 200 20 4 400 20 4 400 100 200 20
w ng pg jjg ng ng jjg ng ng jjg ng ng ng ug
12-43 47 51 55 5 9 3-3 7 11 15 21 59 3 4-7
V 5Hn Bu2 3x106M
8 1 HOUR
Antagonism of s*-hydroxytryptamine (HT) and tryptamine (T)
by 5-hydroxy-N«dibutyl tryptamine (6lHnBu3). Responses are shown to
HT (10, 20 and 200 ng.), T (1, 2, 4 and 20 jj,g.) and acetylcholine
(Ach. 100, 200 and 400 ng,) before and after the action of the analogi
(3 x 10-6M) for 1 hr. At the end of the experiment, dose ratios for
HT was 10, for T it was S and for Ach. it was 0.3,
Figure VIII
Isolated rat uterus preparation
HT T Ach HT T HT Ach HT T Ach HT T HT Ach HT T
10 5 150 5 2-5 5 100 10 5 100 5 2-5 oinO 20 2*5
ng -ug ng ng ng ng ng ng ug ng ng «g ng ng ng wg





10 M 1 HOUR
>
Effect of a low concentration of 2-Methyl-H-dimethyl-
tryptaraine (2MeNMe ), Responses are shown to 5-hydroxytryptamine
(HT 5, 10 and 20 ng.)$ tryptamine (T 2*5 and 5 p.g.) and acetyl¬
choline (Ach. 50, 100 and 150 ng.) before and after the action of
the analogue (10- M) for 1 hr. At the end of 1 hr. the dose
ratio for HT was 1.5; for T it was 0.5 and for Ach. it was 0.5
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TABLE 4
Antagonistic activity of the feeble
















































All the compounds were allowed to act for 60 mins,
except the one marked *» which was allowed to act
for 30 min. only.
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producing such block also depressed the responses
to acetylcholine.
Table II shows the dose ratios for 5-hydroxy-
tryptamine and acetylcholine obtained with a number
of antagonists. With one exception, the antagonism
of tryptamine was about the same as that of 5-
hydroxytryptamine. The exception 2-methyl-N-di-
methyltryptamine (16) appeared to potentiate res¬
ponses to both tryptamine and acetylcholine to some
extent. This potentiation was greatest at the end
of about one hour, (Fig.VIII).
It is convenient to classify the compounds into
(a) antagonists comparable with lysergic acid di¬
ethylamide (which has a drug ratio of 37 on a
molar basis?
(b) moderate antagonists, such as 5-benzyloxy-
gramine (41) ? 5-feenzyloxy N-dimethyltryptamine
(32) and the compounds listed in Table III,
which shows their drug ratios?
(c) feeble antagonists, such as compounds shown in
Table IV.
These compounds had such weak activity that the dose
ratio only was determined. The highest value of
these was below the limit (about 5) at which it is
possible to measure the drug ratio.
All the 5-benzyloxy»3-(2-dialkylaminoalkyl
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indoles seemed to have the same order of activity,
although there was an increase up the series to the
dipropyl compound (34), but none was as active as
5-bensyloxygramine (4^1). This was disappointing,
because Gadaum, Hameed, Hathway and Stephens (1955)
had shown that 5-benzyloxygramine (41) was quite a
potent antagonist of 5-hydroxytryptamine, and it
might be expected that 5-benzyloxy-H-dimethyltrypt»
amine (§2) would be more active because it contained
the aminoethyl sidechain present in 5-hydroxytrypta-
mine. The dibutyl compound (36) was not very
soluble and in the highest concentration tested
(about 6 x 10 M) did not have any effect. The
corresponding 5-hydroxy compound (26) was the only
5-hydroxy compound which antagonised 5-hydroxy-
tryptamine. In the H substituted tryptamine, it
was only N-dimethyltryptamine (g) which had antag¬
onistic activity. This was one-eighth as powerful
as the corresponding 6-benzyloxy compound (. The
most active antagonist was 5-benzyloxy-a-methyl-
tryptamine (§§)» but even this was less active than
5-benzyloxygramine (£L).
K-Diethyltryptamine (4) , when tested in one
experiment (Table 4 ) blocked 5-hydroxytryptaiaine
but the same concentration (4 x 10" M) on a differ¬
ent tissue caused synergism with 5-hydroxytryptamin<
FIGURE A
Rat uterus
Log. dose response curves to 5-hydroxytryptamine (HT) and
5-hydroxy-N-dipropyltryptamine (A).
10.
0... . . . . . a * <-
HT HT HT HT HT A A A A A A
10 15 20 40 80 1-7 2-5 3 4 6-8 13-6 27-2
ng ng ng ng ng pM pM pM pM pM pM
Doses (log. scale)
HT A
(ng. bases 20ng.= 11 p Moles) (p Moles)
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and in yet another experiment, in the same concen¬
tration, caused contraction of the preparation.
Similarly, l-methyl~a-methyltryptamine (18) in one
experiment antagonised 5-hydroxytryptamine, giving
a dose ratio of 4, but in a second experiment (in
„6
the same concentration of 3 x 10 M) on a different
tissue, produced apparent synergism with 5-hydroxy-
tryptamine. In yet another experiment, the same
concentration produced a contraction by itself.
These compounds seem to be substances with only
very feeble antagonistic activity, which is usually
masked by their stimulant properties.
(iii) Stimulant properties ? All the drugs
except the 5-benzyloxy compounds, o-ethyltryptamin^
(12), morpho1inotryptamine (JO) and the quaternary
salts of bufotenine (§&|22) stimulate the rat
uterus, when given in a suitable concentration.
The equipotent molar ratios are given in Table 1.
As with 5-hydroxytryptamine and tryptamine, there
was a latent period of 15-20 sec, before the muscle
started to respond, the contraction lasted about
30 sec, and then passed off, 5-hydroxytryptamine
tryptamine and all the stimulant analogues, except
the N~ substituted tryptamines and 5-hydroxy-dibuty}.-
tryptemine (2$) were easily washed out and the
preparation returned to normal rapidly. The
11 p Moles) Moles)
FIGURE B
Rat uterus




exceptions required more washing before the tissue
recovered and always gave rise to repeated contrac¬
tions, which continued for a few minutes. This is
why the entire dose/response curves for these drugs
could not be obtained and their activity was deter¬
mined only by matching. A special effort was made
to plot the entire dose/response curves for N-di-
methyltryptamine (£) and 5-hydroxy-U-dibutyltrypta-
mine (25), and two substances with both antagonistic
and stimulant activity, and it seemed that with
these drugs, the curves were parallel to 5-hydroxy-
tryptamine only over the lower half (where their
activity was estimated (Fig. B). After contrac¬
tions caused by these two compounds, the tissue was
left insensitive to 5-hydroxytryptamine for up to
30 min. The other compounds in this group (the
purely stimulant N-substituted tryptamlnes) left the
tissue more sensitive to the action of 5-hydroxy-
tryptamine for about 10 minutes when used in doses
which did not give a maximal contraction. Larger
doses, causing maximal contractions, desensitised
the tissue to the test dose of 5-hydroxytryptamine
for 10-15 minutes in a manner apparently similar to
that of larger doses of 5-hydroxytryptamine and
tryptamine.
The remaining compounds (the 5-hydroxy-.
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5-methyl~, 5-methoxy- and a-methyl derivatives of
tryptamine) caused contractions apparently the same
as those produced by 5-hydroxytryptamine and tryp¬
tamine, and were easily washed out. Their dose/
response curves were parallel to that of 5-hydroxy-
tryptamine and these drugs only affected the
response to the test dose of 5-hydroxytryptamine,
when high doses were used. In these circumstances
they reduced the response slightly.
The most active compound was 5-hydroxy-a-
methyltryptamine (gO) and the next most active were
5-methoxy-a-methyltryptamine (gl) and bufotenine
(21). The activity in the series of 5-hydroxy-N-
dialkyItryptamines declined as the length of the
alkyl group was increased, whereas, in contrast,
the activity rose slightly from the dimethyl to the
dipropyl compound in the series of simple N-dialkyl-
tryptamines. The 2-methyl were almost as active as
the simple N-dialkyl tryptamines except the dimethyl
compound, 2-methyldimethyl tryptamine (16), which was
less than one-twentieth as active as N-dimethyl-
tryptamine (g). The three N-monoalkyl analogues
had activity much lower than the corresponding N-
dlalkyl derivatives.
The effects of the size of the alkyl group on
activity is shown in Flg.a&H. The 5-methyl group,
PiRure IX
Isolated rat uterus preparation
HT HT HT HT HTjPrHTHT HTiP^HT HT IP^HT
5 5 10 20 5 0*8 5 5 0-4 5 0*2
ng ng ng ng ng nMol ng ng nMol ng nMol
Stimulant activity of 5-hydroxytryptamine (HT 5, 10 and
20 ng.) and 5-hydroxy-N-diisopropyltryptaiaine (IPr0HT 0.2, 0.4 and
O.S n. MoleX A S ng. test dose of 5—HT is applied before every
application of the analogue, to make sure that the sensitivity
of the uterus is uniform.
10 ng. of HT = 5.5 p. Moles.
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and to a much greater extent, the 5-benzyloxy group
and the ethyl group at the a-position, reduced the
stimulant activity. The quaternary salts were in¬
active, as were also, although these are not inc¬
luded in the table (I), the glyoxylamides, 3-(5-
benzyloxy)-indolylglyoxyldimethylamide and 3-(2-
methyl)-indolylglyoxyldimethylamide, which were
intermediates in the synthesis of the tryptamines
and hydroxytryptamines. S-Hydroay-o-methyltrypta-
mine (20) was half as active as 5-hydroxytryptamine ,*
5-raethyl- a-methyltryptamine (gl) was l/8th as
active as 5-raethyltryptamine (§0), 5-methoxy-a-
methyltryptamine (29) was twice as active as 5-
methoaytryptamine (28) and a-methyltryptamlne (11)
l/4 as active as tryptamine,
(!▼) Production of repeated contraction; 5-
hydroxytryptaraine and tryptamine, when applied to
the tissue for 5-10 min, in a concentration some¬
what higher than the one causing maximum contract¬
ion, caused repeated contractions. All the com¬
pounds, except the 5-benzyloxy derivatives also did
this when added to the bath in a high enough con¬
centration. Some of the N-substituted tryptamines
(see p. 82), produced repeated contractions which
persisted for some time, even when applied in mod¬
erate doses and after repeated washing of the
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preparation. After such treatment, the tissue was
more sensitive to the action of 5-hydroxytryptamine
for a few responses, hut, when repeated contractions
were produced by the compounds including 5-hydroxy-
tryptamine and tryptamine, the tissue was less sen¬
sitive to the test dose of 5-hydroxytryptamine for
a few minutes*
(v) Profound depression: In still higher
concentrations, the preparation was quiet and in¬
sensitive to 5-hydro3tytryptamine. The responses
to acetylcholine were not always affected, but were
blocked by raising the concentration of the drug
still further.
2. EFFECTS ON THE BAT FUKDUS STRIP
The highest concentrations tested on this
preparation were not usually greater than those
which produced a maximum contraction (varying with
the stimulant activity of the compounds, usually
around 10 M), because on the occasions when the
drugs were tested in concentrations above this,
they did not give rise to repeated contractions or
profound depression, such as was observed in the
rat uterus. The actions of these compounds can
again be divided into?





Antagonistic activity of bromo-lysergic acid
on the rat fundus strip at 37°C to 5-hydroxytrvptamine
and other indoles








j amine tryptamine MeaN nPraN choline
Bromo*
Lysergic- 0.5 X 10 1.5 1 - - mm 1
acid di¬ !
ethylamide 1.2 40 4 - m - 1
50 7 * 40 - 1
15 m - - 15 1
[ 5 2 - >10 • 1
! 10 5 - 10 1
\
I
75 10 15 - - 1
2.5 20 7 mm 1
60 8 8 * - 1
3.7 40 10 - 40 1
25 6 - 53 mm 1
400 20 20 mm - 2
7.5 100 10 mm m mm 1
25.0 130 >10 mm m mm 1
>200 6 m m 1
5-HT « 5-hydroxytryptamine
MeaN » N-dimethyl-tryptamine (g)
nPraH a= N-dipropyl-tryptamine (§)
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TABLE 6
Antagonistic activity of indoles on the































































































































Insults with bromo-lysergic acid diethylamide
have been included from Table 5 for comparison.
The antagonistic effect required 30-40 mins. to develop completely,
and this period was allowed for the action of l-Benzyl-2-methyl-5-
methoxytryptamine, but in experiments with other compounds, they
were allowed to act for 60 mins.
* Means potentiation, which was much marked at the beginning of
the experiment.
Rat fundus strip preparation
HT T Ach HT T W HT T HT T T HT Ach
20 20 100 5 5 5 5 10 5 5 50 100
ng pg pg ng Oq ng pg ng pg pg ng pg
TIME 11*30 35 40 50 55 12-2 5 1 0 25 30 50 55 1 PM
-6
NZ 2MeNMeg 2X10 M 1 HOUR
' 12
Effect of a low concentration (2x10" M) of 2-methyl-N-
dimethyltryptamine (2MeNMea). Responses are shown to 5-hydroxy-
tryptamine (HT 5, 10, 20 and 50 ng.). Tryptamine (T, 5 and 20 p,g.)
and acetylcholine (Ach. 100 pg.) before and after the action of the
analogue. At 12 noon, when the analogue was first maintained in the
bath, the base line rose by about 3 cms, and the tissue was given an
additional wash (W), and stretched. The base line tended to stay
higher during the rest of the experiment. Dose ratios at the end
of 1 hr. were 10 fox* HTf about 1 for T and Ach. The T responses
were significantly, potentiated in the early part of the experiment.
Hyoscine 2.3x10" M maintained in Tyrode solution.
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(iii) Depression of 5-hydroxytryptamine
response.
(i) Modification of the responses to 5-hvdroxv-
tryptamine and Tryptamine. To see if there was
any synergism with 5-hydroxytryptamine or tryptamine
at low concentrations, such as was observed on the
rat uterus, the drugs were added to the tyrode sol¬
ution so that the preparation was continuously in
s
the presence of a low concentration (10" M) of the
compounds. None of than showed any synergism with
5-hydroxytryptamine, even when allowed to act for
60 min, in a concentration high enough to cause a
rise of the base line.
Two of the compounds, however, 2-methyl-N-di-
methyl (16) and 2-methyl-N-diethyl-tryptamine (17)
enhanced the initial responses to tryptamine.
Three of the compounds, N-dimethyl-, 2-methy1-
N-dimethyl and 5-benzyloxy-N-dimethyl tryptamines
antagonised 5-hydroxytryptamine, but
did not antagonise tryptamine to quite the same
extent. The dose ratios of these and of 5-benzyloxy-
gramine (£L) which also blocked 6-hydroxytryptamine
to a greater extent than tryptamine, are given in
Table 566. The 2-metnyl-N-dimethyltryptamine (16)
enhanced the responses to tryptamine at the same
concentration as it antagonised 5-hydroxytryptamine,
This effect was much more noticeable in the
Figure XI
RAT FUNDUS STRIP 37°C : 5ml. bath: I-4 mag.:
TYRODE CONTAINS HYOSCINE 2-3XlO~7M.
HT T Ach HT T T HT T HT Ach
5 5 12-5 IO IO 20 500 50 1 12-5







Effect of bromolysergie acid diethylamide (BOL 2.6x10 M).
Responses are shown to 5-hydroxytryptamine (HT 6, 10 and 600 ng.
and 1 p.g.). Tryptaiaine (T6, 10, 20 and 60 p,g.) and acetylcholine
Ach. 12.5 p.g.) before and after the action of BOL for 1 hr. Note
that the antagonism of HT is 25 times that of T, while Ach responses
are unaffected„ Etyoseine 2.3xlO~7M maintained in Tyrode solution.
Figure XII
RAT FUNDUS STRIP 37°C; 5ml. bath: 1-4 mag.
_7
TYRODE CONTAINS HYOSCINE 2-3 X IO M.
HT T Me^N Ach HT T M^N Ach
5 5 6-5 IO IO IO 13 20
ng jjg nM. jjg nq Jjg n ^g
M«2N= n-dimethyltryptamine
Me^N Ach T
65 20 2 O
n M jj g pg










Effect of a low (3.3 x 10 M) concentration of N-dimethyl-
tryptamine. Responses are shown to 5-hydroxytryptamine (HT 5, 10
and 100 ng,)j tryptaraine (T, 5, 10 and 20 ug.)j analogue (6.5,
13, 65 and 650 n. Moles) and acetylcholine ^Ach, 10 and 20 p,g.)
before and after the action of a low concentration of the analogue.
Note that the base line has gone up by about 3 cms. after the ana¬
logue was maintained in the bath. The dose ratios at the end of
1 hr were 10 for HT., about 2 for T, 50 for the analogue and 1 for
Ach. Hyoseine 2.3xl0-7M maintained in Tyrode solution.
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beginning of the experiment than at the end (Fig.X).
N-Dimethyltryptaraine ( g) antagonised 5-hydroxy-
tryptamine but did not have any significant effect
against tryptamine, It was not possible to test
1 ' '
higher concentrations of these substances, because
these drugs themselves caused contractions (Fig.XIlI)
The antagonism reached its maximum at about 1 hr.
and the recovery process also took about the same
time.
On this preparation 5-benzyloxygramine (41) was
a less potent antagonist than S-benzyloxy-H-dimethyl
'
tryptaraine (32) and even less than N-dimethyl-
tryptamine (£). The antagonistic effects of 5-
benzyloxy-N-dimethyltryptamine (32) appeared to be
greater on the rat fundus than on the rat uterus.
On the rat fundus strip, W-dimethyltryptamine (2)
and 5-benzyloxy-N-dimethyltryptamine (32) were about
equi-active, whereas on the rat uterus, the latter
was more powerful.
This preparation seems to be very sensitive to
the stimulant properties of these compounds. Antag¬
onistic activity was confined to the three compounds
which contained the dimethylamino group.
;ii) Stimulant action. All the compounds, except
h^morpholinotryptamine (10), all the quaternary
salts (g6, 27, 39, 40), 5-benzyloxy-N-dibutyl and
RATFUNDUSSTRIP
Log.doseresponsecurvet5-hydroxytryptamine(HT)andtryptamine(T) Dose(log.scal ) HTT (ng.base)(p.g.base)
Ffrgupe TO
Rat fundus strip preparation
HT 2MeNMe2HT 2MeNMe2
5 210 5 840
ng nMol ng n Mol
TIME 12-50 55 1-15 1-20
/o-, stimulant activity of 2-methyl-N-dimethyltryptaminei2MeHMea). Responses are shown 6o 6-hydroxytryptamine (HT, 5 ng.
and the analogue (210 and 840 n. Moles). Ifcroscine 2.3 x 10-M
maintained in Tyrode solution.
HT 5 ng. = 2.8 p. Moles.
Figure XIV
Rat fundus strip preparation
HT HT HT HT HT HT HT HT HT HT HT
5 5 20 5 5 5 40 5 5 5 80
ng ng ng ng ng ng ng ng ng ng ng
T'ME IOSO 55 11 5 10 15 20 25 30 35 40
HT NMsT HT NMeT HT HT NMeT HT HT HT HT NMeT
5 95 5 380 5 5 760 5 5 5 5 1-5
ng nM ng nM ng ng nM ng ng ng ng ;jM
12*25 30 35 40 45 50 55 1PM 1*5 10 15 20
Stimulant activity of 5-hydroxytryptamine (HT) and
N-methyltryptamine (HMeT), Responses are shown to HT (5, 20,
40 and 80 ng.) and to the analogue (95, 380 and 760 n. Moles
and o.5 p. Moles). Note that the 5 ng. test dose of HT is
applied in between the high concentrations of HT and all the
applications of the analogue to see that the sensitivity of the
preparation is uniform. After higher concentrations of HT and
the different applications of the analogue there is a tendency
for the base line to go up and so additional period of stretch
was applied (multiple verticle lines). Ifyoscine 2.3 x 10-7M
present in Tyrode solution.
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N-morpholinotryptamines (£56, 37) and the intermedi¬
ate glyoxylamides (mentioned on p. 84) stimulated the
preparation. The compounds listed as antagonists
in Table 6 also showed this effect at concentrations
greater than those which produced antagonism. The
stimulant activity is summarised in Table 1. 5-
hydroxytryptamine, tryptamine, 5-hydroxy-a-methyl-
tryptamine (20), 5-methoxytryptamine (28) and 5-
methyltryptamine (30) caused contractions which
reached a maximum within 90-120 sec. and which
passed off after washing and stretching for about
one minute. On the other hand, those 5-benzyloxy
compounds which were active, a-methyltryptamine (111,
3-(2-dipropyl-N-dipropyltryptamine (5) and 1-methyl-
a-methyltryptamine (19) required 2 to 3 mins. for
the completion of the contractions, and 30-45 min.
for stretching and recovery. Thus one assay of
these long-acting drugs requires a whole day. The
remaining compounds fall between these two extremes.
The dose/response curves of all the compounds
(except those containing a 5-benzyloxy group)
appeared to be parallel to those of 5-hydroxytrypta-
mine and tryptamine. The 5-benzyloxy compounds
did not give a maximal response, although at lower
dose levels the curves were parallel to those of
5-hydroxytryptamine, and it was at these levels that
the equipotent molar ratios were determined (Fig.D).
Figure XV
Rat fundus strip preparation
HT HT HT 5BzOEt2HT 5BzOEt2 H T 5BzOEt2
10 100 10 14 10 56 10 560
ng ng ng nM ng nM ng nM
TIME 11-20 25 40 45 50 55 12-15 20
Stimulant activity of 5-hydroxytryptamine (HT) and 5-benzyloxy-
N-diethyltryptamine (5BsOEta). Responses are shown to HT (10, 100 ng.)
and the analogue (14, 56 end 560 n. Moles). A test dose of 10 ng. of
HT was applied before each application of the analogue to test for the
sensitivity of the preparation. Note also that increasing the concen¬
tration of the analogue from 56 n.Moles to 560 n.Moles, no increase in
the contraction resulted, l^hile a similar 10-fold increase in the dose





The most active compounds were S-hydroxy-a-
methyltryptamine (20) and 5~methoxy-a-methyltrypta~
mine (§9). The next most active were bufotenine
and 5-hydroxy-N-di-isopropyltryptaralne, The vari¬
ation of activity with structure in the series of
5-hydroxy*2-F-dialhyl tryptamines was slightly diff¬
erent on the rat fundus from what it was on the rat
uterus. The diethyl compound, which was inter¬
mediate in activity between bufotenine and the di-n-
propyl compound on the rat uterus, is less active
than the dipropyl compound (23) on the rat fundus.
Also, relative to tryptamine, the di-lsopropyl com¬
pound is more active on the rat fundus than on the
rat uterus.
In the H-substituted tryptamines the most
active compounds were N-dipropyltryptamine and alpha-
metbyltryptamlne. In the 2-methyl substituted com¬
pounds, 2-methyl-K-dipropyltryptamine was most
active and 2-methyl-W-dimethyltryptamine was only
relatively feeble, suggesting that the 2-methyl group
lowered the stimulant activity of M-diraethyltrypta-
mine considerably. In the monoalkyl substituted
tryptamines, the most active compound was the ethyl
derivative. The effect of the size of the alkyl
group on activity is shown in Pig, G and H.
It was noted that, whereas a-methyltryptamine
FIGURE XVI
Isolated rat fundus preparation
Stimulant action of 5-benzyloxy-N-dimethyltryptaraine.
a. Responses to 10 ng, of 5-hydroxytryptamlne (10) and 0.3 p.M.
of 5-benzyloxy-N-dlmethyltryptamine (0.3) at time 12.28.
b. Responses to 10 ng. and 100 ng. of 5-hydroxytryptaraine (10
and 100) at 14.05,
c. Responses to 10 ng. of 5-hydroxytryptamine (10) and a combined
dose of 0.3 p.M. of 5-benzyloxy-R-dimethyltryptamine plus 100 ng.
of 5HT (0.3 + 100) at 14.20,
d. Responses to 10 ng. and 100 ng. of 5HT at 15.45.
e. Responses to 10 ng. of 5HT (10) and to 200 pg. of acetylcholine
(200) at 16.15.
f. Responses to 10 ng. of 5HT (10) and to a combined dose of 0.3 p.M.
of 5-benzyloxy-N-dimethyltryptamine plus 200 pg. of acetylcholine
(0.3 + 200). The results suggest that 5-benzyloxy-N-dirnethyl-
tryptamine acts at the same receptors as 5HT but not at those
acted upon by acetylcholine.
Time in min.
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was 15 times more active than tryptamine, 5-methyl-
a-methyltryptamlne was 30 times more active than 5-
methyltryptamine, 5-methoxy-a-methyltryptamine was
20 times more active than 5-methoxytryptamine, but
5-hydroxy-a-methyltryptamine was only half as
active as 5-hydroxytryptamine. Also dl~&-propyl-
tryptamine was 20 times more active than tryptamine,
but 5-hydroxy-N-dl-ji-propyltryptamine was only l/l6
as active as 5-hydroxytryptamine. The methoxy com¬
pounds were again, as on the rat uterus, more
active than their 5-methyl analogues.
Of the 5-benzyloxy compounds, the 5-benzyloxy-
a-methyl-tryptamine (14) was most active, but
potency in this series, though declining in higher
members, did not follow the same pattern as in the
corresponding 5-hydroxy compounds. These compounds!
did not give a maximal response, To see if they
acted on the same receptors as 5-hydroxytryptamine,
a benzyloxy compound in a concentration which
produced the biggest response obtainable, (of the
N-diethyl compound, 6 x 10*"8M: of the N~dimethyl
compound, 5 x 10"6M) was added simultaneously with
a dose of 5-hydroxy tryptamine (100 ng. in a 5 ml,
bath) which, by itself, produced a bigger effect
than the 5-benzyloxy compound. In these circum¬
stances (Fig,XVI) the response was smaller than
that to the dose of 5-hydroxytryptamine alone.
93
When a dose of acetylcholine ( 200 p,g, a large
amount because there is hyoscine in the tyrode sol¬
ution) was used in place of 5-hydroxytryptamine,
there was no depression of the response to acetyl¬
choline. This suggested that the 5-benzyloxy
compounds occupied the same receptors as 5-hydroxy-
tryptamine, but not those acted on by acetylcholine,
Ciii) Depression of 5-hvdroxytryptamine responses.
After stimulation with the compounds, 5-
hydroxytryptamine and tryptamine, the preparation
was insensitive to the small doses of 5-hydroxy~
tryptamine for a variable time, depending on the
dose and the type of drug used. It was more
marked after the long-acting drugs like the a-methy],
derivatives (other than 5-hydroxy-a-methyltryptamine)
and the 5-benzyloxy compounds. When the dose
response curves were being obtained, it was particu¬
larly necessary to allow time for this depression
to pass off and to wait till the control responses
to 5-hydroxytryptamine returned to normal before
proceeding further.
3. EFFECTS ON THE GUINEA FIG ILEUM
Introduction. As already mentioned (p. 65) it was
first necessary to establish that the tryptamine
receptors in this preparation are affected similarly
by both 5-hydroxytryptamine and tryptamine. To do
this the dose ratios of tryptamine and morphine and
FIGURE E
Guinea ileum
Log. dose response curves to 5-i
before and after the action of LSD 3x10'•hydroxytryptamine
Responses to HT (base) are shown as A (before the
of LSD) and B (after the action of LSD).action
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TABLE 7
Antagonistic activity of lysergic acid diethyl-




































































3*5x10 3 t o.am 3 i 0.5CSE) 3.510.4
S.E.
1 1 0
• , means not tested (See text, page 95
The two limits of the ratios for dibenzyllne and lysergic acid
diethylamide are given at the two extremes of the dose/response
curve to 5-hydroxytryptamine and tryptamine (See text, page 95^
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and tryptamine and lysergic acid diethylamide were
compared with those of 5-hydroxytryptamine and the
same antagonists. The results are shown in Table
7, and appear to be the same, Dibenzyline-treated
tissue was so insensitive to the action of trypta¬
mine, that no attempt was made to obtain dose ratio?
with tryptamine. The dose ratio figures during the
presence of dibenzyline and lysergic acid diethyl¬
amide are given as a range because after the prepar¬
ation was treated with these drugs, the dose/responSe
curves to 5-hydroxytryptamine and tryptamine,
although parallel with each other, were not parallel,
with the original curves (Fig, E). Gaddum and
Piearelli (1957), (Gaddum, Personal Communication),
had difficulty in obtaining dose ratios with lysergic
acid diethylamide, because the base line was disturb¬
ed by this drug - it was for this reason that they
used dibenzyline instead, to block the "D" receptors -
but no great trouble of this sort was encountered in
these experiments. The results seemed to indicate
that tryptamine and 5-hydroxytryptamine acted at
the same receptors in the guinea pig ileum. It was
therefore, reasonable to proceed to test these
compounds for their ability to imitate or antagonise
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- Means not tested.
On "M" receptors (Dibenzyline treated tissue) the analogues were
maintained in the bath for only 15 min. as their effect was negative.
The antagonistic action of N-dimethyltryptamine and 5-benzyloxy-N-
dimethy1tryptamine against 5-hydroxytryptamine were complete at the
end of one hour, but their anti-histaminie effect was complete at the
end of 15-20 min. only, 5-henzyloxygramine blocked the action of
5-hydroxytryptamine to a maximum extent after 20 min. contact, while
the anti-nicotinic effect of 5-benzyloxy-N-dimethyltryptaraine progressed
beyond the end of one hour.
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Only the compounds listed in Table 10 were
tested (for both stimulant and antagonistic action)
on this tissue. As in the rat uterus, their
actions can be divided intot
(i) Antagonistic activity.
(ii) Stimulant activity.
(iii) Effects of higher concentrations.
Civ) Effect of temperature.
(v) Effects of increasing the
concentration of morphine or
lysergic acid diethylamide.
(i) Antagonistic activity. In the presence of
morphine (i.e. on the "DP receptors which are
thought to be in the muscle part of the gut), only
three of the compounds examined had antagonistic
activity. On the dibenzyline-treated tissue (i.e.
the " Jf1 receptors which are thought to be in the
nervous part of the gut), none of the compounds,
even of these three, had any antagonistic activity
in the same concentration as in the test on the 11D"
receptors. These results are summarised in Tables
8 and 9.
Costa (1956) has reported that reserpine antag*
onised 5-hydroxytryptaiaine in the rat uterus and
suggested that other substances, which are tranquil¬
lizers, might do the same. He showed that some
compounds which produced hallucinations (e.g. lyser-
ic acid diethylamide and mescaline) increased the
aausjBii
Isolated guinea pig ileum preparation
C N HT H HT N HT N HT H HT HT N C
20 2 4 4 10 1-5 20 4 100 20 2 300 200 20
ng pg ng ng ng pg ng/ig ng ng /ig ng pg ng
TIME 3-44 4"0 5 9 13 17 21 25 29 33 5-6 10 14 5-1B
"6
\J/ 5BZOMc2 6-2X10 M
19 1 HOUR
Antagonistic effect of 5-benzylozy-N-dlrriethyltryptamine
(SBzOMejj) on the HD" receptors (in the presence of morphine 3.5x
10~6M). Responses are shown to 5«hydroxytryptamine (HT, 4, 10,
20, 100, 300 ng, and 2 ^g.)$ nicotine (N, 1.5, 2, 4 and 200 p.g.)f
histamine (H, 4 and 20 ng,) and carbachol (C 20 ng,) before and
after the action of analogue (6,2 x 10"6M), At the end of 1 hr,
the dose ratios are 33 for HTf 132 for 20 for H and 1 for C.
The last response to H is not shown in the tracing.
TABLE 9
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Antagonistic activity of some indoles on the











Mean drug ratio (molar










60 3 0.33 Z 0.1
3 N-dimethy1-
tryptamine 66 3 0.055 Z 0. 002
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responses to 5-hydroxytryptamine In the rat uterus
(P. 13). Gaddum (personal communication) consider¬
ed that the HM" receptors in the guinea pig ileum
(thought to be in the nervous part of the tissue),
might be a more suitable model for testing the
central activity of the compounds. Reserpine was
therefore tested on the dibenzyline-treated tissue
and was found to be without effect. This was dis
appointing, and indicated that this tissue could not
be used to obtain an idea of the central action of
the compounds.
Two Interesting side-effects were observed in
the guinea pig ileum treated with morphine (H
receptors)•
1) 5-benzyloxy-N-dimethyltryptamine (§)
antagonised the effects of nicotine (Fig.XVII^ These
effects of nicotine have been termed "morphine-insen¬
sitive" by Kosterlitz and Robinson in 1959).
2) U-Dimethyltryptamine (g) and, to a
lesser extent, 5-benzyloxy-H-dimethyltryptamine (32)
antagonised the effects of histamine on this prepar¬
ation.
(ii) Stimulant activity a The stimulant activity of
the compounds tested is shown in Table 10, In the
presence of morphine, contractions produced by all
the stimulant compounds,including 5-hydroxytryptamihe
and tryptamine, were complete within 30-46 sec.
100
5-Hydroxytryptamine, tryptamlne and 5-hydroxy-a-
methyltryptamine (20) all appeared to be easily
washed out, but after the other compounds a longer
time (usually 2 min.) was required before the tissue
relaxed. In concentrations used for plotting the
dose/response curves the drugs produced a single
contraction of the muscle (not repeated contractions)
N-Diraethy1tryptamlne (2) caused slight depression
(lasting about 5 min.) of the control responses to
5-hydroxytryptamine after a high concentration had
been given, but after the other compounds the con¬
trol responses were not disturbed.
The dose/response curve of N-dimethyltryptamine
(2), though parallel to those of 5-hydroxytryptamine
and tryptamine in low concentrations, flattened out
in higher concentrations (as Fig.B).The curves of
the other active compounds were parallel to those of
5-hydroxytryptamine and tryptamine over the whole
range. Of the compounds tested, 5-benzyloxygramine
(41), 5-benzyloxy-N-diethyltryptamine (§2) and a-
ethyltryptamine (12) were inactive. a-Methyl-
tryptamine (11) and U-dipropyltryptamine (§) were
about as active as tryptamlne, and 5-hydroxy-a-
methyltryptamine (§0) was about half as active as 5-
hydroxytryptamine.






















Guinea pig ileum (LSD 3x10"SM in Tyrode






Isolated guinea pig ileum preparation
f
250 500 200 500
ng ng jjg ng
800 500 710
nM ng nM
Action on UM" receptors. (Preparation treated with difcenzyl-
line). Responses are shown to 5-hydroxytryptamine (HT 250 and 500 ng
tryptamine (T, 200 pg.), a-methyltryptamine (a-Me T» 800 n. Moles)
and N-dipropyltryptamine CnPra 710 n. Moles). Time in rain.
HT 500 ng. « 275.0 p. Mole
T 200 p,g. =s
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hydroxy-a-methyltryptamlne (20) was the only com¬
pound which was active enough for a dose/response
curve to be determined. This was parallel to that
of 5-hydroxytryptamine (Fig. F). The other com¬
pounds tested only produced small effects even in
very high concentrations (Fig. XVIII).
In the presence of lysergic add diethylamide
dose/response curves were obtained with a few com¬
pounds (Table 10), 5-Hydroxy-a-methyltryptamine
CSO) was again the most active and its dose/responsie
curve was parallel to those of 5-hydroxytryptamine
and tryptamine. N-Dipropyl- and 5-hydroxy-N-di-
propyl- tryptamines (&, 23) were the next most
active, being stronger than tryptamine, but their
dose/response curves flattened out at high concen¬
trations. The effects of these latter compounds
can only be shown on the "M" receptors when the "D"
receptors are blocked by lysergic acid diethyl¬
amide. Dibenzyline leaves the tissue so insensit-
itive (even to 5-hydroxytryptamine) that responses
to the less active compounds could only be expected
with very high concentrations indeed.
One of the most striking features of Table 10 is
the high activity of N-dipropyltryptamine (J>) on
the receptors. This resembles the results on
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5 N-dipropyl-
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t indicates the dose/response curve was not parallel to that of 5-hydroxy-
tryptamine.
+means just threshold responses, no idea of the dose/response curve,
-means not tested.
: Bquipotent molar ratio was 14017 (S.E.) (5)Expt.during normal Tyrode
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the dose/response curve is parallel to that of 5-
hydroxytryptamine over the whole range.
One of the most puzzling results in Table 10 isi
the activity of tryptamine relative to S-hydroxy-
tryptamine. This does not appear to be the same
on the "M" and 14D" receptors. Further, the actlvi
of 5~hydroxytryptamine on the normal gut is less
than would be expected, if 5-hydroxytryptamine and
tryptamine act only on the "H* and "D" receptors.
These results may merely emphasise the errors
involved in these experiments, or they may indicate
that 5-hydroxytryptamine and tryptamine act differ¬
ently at the different reoeptors, and even suggest
the existence of other receptors in the tissue,
where these drugs may act. Whatever the answer
may be, the situation is obviously extremely compli
cated and the idea of testing all the compounds on
this tissue was dropped.
(iii) Effects of higher concentrations. On thi
preparation, either in presence of morphine or on
the dibenzyline-treated tissue, there was no indi¬
cation of the production of repeated contraction
such as was seen on che rat uterus. A multiple
response was sometimes seen but the tissue rapidly
relaxed in spite of the presence of the drug.
The preparation was then insensitive to 6-
BSttKeJEg
Isolated guinea pig ileum ^reparation
HT H HT N HT. HT. HT
60 3 10 1-5 15 5 20
ng ng ng fjg ng ng ng
Id




W.HT. HT HT HT HT HT H HT HT HT H' N
40 40 80 160 400 8003 1 700 800 3 VS
ng ng ng ng ng ng ng pg ng ng ng >jg





2-2x10 M 1 HOUR
Test for repeated contractions and tachyphylaxis on the
"D" receptors (in the presence of morphine 3.5 x 10~6M). The
analogue used is 5-hydroxy-a-methyltryptamine9 aMeHT, 2.2 x 10-6M).
Responses are shown to 5-hydroxytryptamine (HT, 5, 10, 15, 20, 40,
60, 80, 160, 400, 700, 800 ngs. and 1 &tg.). Histamine (H, 3 ng.)j
nicotine (N, 1.5 p.g.) before and after treatment with the analogue.
No repeated contractions, like those seen on the rat uterus, were
produced and the base line assumed normal level. At the end of
1 hr, there was a marked depression of the responses to HT but no
significant effect against H and N.
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hydroxytryptamine and tryptamine (even if the drug
was washed out) but the control responses to nico¬
tine , acetylcholine and histamine were unaffected.
This type of effect was also produced when lower
concentrations (below those producing a maximal
response) were left in for a long time (more than
5-10 min.) (Fig.
(±v) Effect of temperature. In the first
experiments on the guinea pig*s ileum, the tempera¬
ture was 35°C. and the work was complicated by the
spontaneous activity of the tissue. In order to
avoid this, the temperature was reduced to 28°C,
At this temperature, it was found that the effects
of morphine were very feeble. The dose ratios
_ 6 j.
using 3.5 x 10 M morphine were 1.6.0,36 for 5-
hydroxytryptaraine and 1.4*0.4 for tryptamine (mean
of 6 experimentstthe standard error) whereas at
35°C. they were 3.0*0.5 and 3.0*0.5 (Table 7). This
result was surprising. Kosterlitz and Robinson
(1957 and 1958) and Innes, Kosterlitz and Robinson
(1957) found that contractions of the longitudinal
muscle of the guinea pig ileum in the "preparatory
phase" of the peristaltic reflex, and contractions
produced by nicotine, barium ions, or 5-hydroxy-
tryptamine were all reduced by morphine, atropine,
or lowering the bath temperature. It might there¬
fore be expected that responses to 5-hydroxytrypta-
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mine would be reduced more by morphine and lowering
the temperature together than by either dose. The
results suggest that the actions of morphine and of
lowering the temperature may be similar.
v) Effect of increasing the concentration of
morphine and lysergic acid diethylamide. Kosterlit
and Robinson (1955,1953) showed that increasing the
concentration of morphine above a certain level
m 7
(1.7x10" M) did not increase the antagonism: a con-
6
centration 1,000 times as big (8x10" M) did not pro¬
duce any greater antagonism of 5-hydroxytryptamine,
nicotine or barium ionsj Gaddum and Picarelli (1957!)
found that with 3.5x10 M morphine "the "If1 receptors
appear to be more or less completely blocked", Gaddnm
and Hameed (1954) have shown that increasing the con¬
centration of lysergic acid diethylamide from 3xlQ~aM
to 3x10 M did not increase the antagonism of 5-
hydroxytryptamine,
These experiments were repeated using trypta-
mine, nicotine, and acetylcholine as well as 5-
hydroxytryptamine and it was found that tryptamine
behaved like 5-hydroxytryptamine. The concen-
~6
tration of morphine used (3,5x10 M) produced a
maximal antagonism of 5-bydroxytryptamine, trypta-
mine and nicotine but had no effect on responses
to acetylcholine. A ten-fold increase in the
concentration of morphine did not increase the
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TABLE 11
Stimulant activity of some compounds










2 Tryptamine 6 Z 1.7 3
20 5-Uydroxy-a-methyl
tryptamine 6 Z 1.2 3






3 + 1 3
Figure XX
Isolated perfused rabbit«s ear preparation
Effect of 5-hydroxy-a-methyltryptamine (aMeHT). Response
are sho\m to 5-hydroxytryptamine CHT, 0.5 and 1 ng.),- tryptamine
1 n* and 6 and oMeHT 2.4 and 24 P Moles. 0.05 ml. of Greenand Page solution (G.P.sol.) had no effect.
HT 1 ng. » 0.65 p Mole.
T 5 ng. = 3.7 p Moles.
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antagonism of 5-hydroxytryptamine, tryptamine and
nicotine (and had no effect against acetylcholine).
The concentration of lysergic acid diethylamide
, -s
used (3x10 M) produced maximum antagonism of 5-
hydroxytryptauiine and tryptamine but had no effect
against nicotine.
4. Effects on the perfused rabbit's ear.
Only the compounds shown in Table 11 were
tested on this preparation. Small doses of 5-
hydroxytryptamine| tryptamine, 5-hydroxy-a-methy1-
tryptamine (20) and adrenaline, all caused vasocon¬
striction. The vasoconstrictor effect of moderate
doses of these compounds passed off in 3-10 minutes*
The dose response curves seemed to be parallel
(Fig.XX) although there is only a small range of
doses which can be given, which makes it difficult
to Judge exactly. Equipotent molar ratios were
determined and are shown in Table 11. N-Dipropyl-
tryptamine (£) and 2-methyl-H-dimetbyltryptamine
C&§) were practically without vasoconstrictor pro¬
perties, but both compounds antagonised the effects
of 5-hydroxytryptamine, tryptamine and adrenaline.
The H-dipropyltryptamlne (£) showed this effect in
the range of 35 n Mol to 525 n Mol, and was more
active an antagonist than the 2-methyl-N-diaethyl-
tryptamine (16). About 50 minutes after a single
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262 n Mol dose of N-dlpropyltryptamine (i.e. Just
before recovery commenced), the dose ratios for 5-
hydroxytryptamine and adrenaline were 100, 200 and
10 respectively when the recovery process started.
After 10 min. after a 420 n Mol dose of 2-methyl-N-
dimethyltryptamine (i6)» the dose ratios for 5-
hydroxytryptamine and adrenaline were about 10 each
5. DIFFERENCES BETWEEN THE EFFECTS OF
5~HYDR0XYTRYPTAMINE AND TRYPTAMINE
CD Introduction. In the course of test¬
ing the antagonistic properties of the compounds it
seemed that some substances antagonised 5-hydroxy-
tryptamine more than they did tryptamine. This
effect was, therefore, studied by determining the
dose ratios for 5-hydroxytryptamine, tryptamine and
acetylcholine of the compounds concerned. On the
rat uterus (Table 2) one compound, 2-methyl-N-di-
raethyltryptamine (16) in a concentration of 10 M
potentiated the effects of tryptamine and acetyl¬
choline but not those of 5-hydroxytryptamine (Fig,VIII).
With the other compounds, however, there is not a
convincing difference between the dose ratio figures
for 5-hydroxytryptamine and tryptamine (Table 2).
On the rat fundus strip, the situation is
clearer. 2-Methyl-N-dimethyltryptamine (jL6), N-di-
raethyltryptamine ( £), 5-benzyloxy-N-dimethyltrypta-
mine (32), 5-benzyloxygraralne (41), and also bromo-
lysergic acid diethylamide are much more effective
antagonists of 5-hydroxytryptamine than of trypta-
mine (Table 6)* These findings might be taken to
mean that, even though the dose response curves for
5-hydroxytryptamine and tryptamine are parallel on
both the rat uterus and rat fundus strip, 5-hydroxy¬
tryptamine and tryptamine act at different recept¬
ors, and that the compounds listed in Table 6 block
the 5-hydroxytryptamine receptors much more than
they block the tryptamine receptors. This idea
was suggested by Woolley and Shaw (1957c) to
explain their finding that BAS (42) and BAS phenol
• I-;':;'. . . . ; ' ' ' ■ \'j • . • : ; . ' . . , , • •/
(see page 42) antagonised the effects of 5-hydroxy¬
tryptamine mueh more than those of tryptamine on
the blood-pressure of anaesthetised dogs.
Another possible explanation is that 5-hydroxy-
tryptamine and tryptamine act at the same receptors
but that the compounds both block the receptors and
simultaneously potentiate tryptamine. This would
necessitate an action by the compounds on the
■
receptors in the same concentration as on an enzyme
destroying tryptamine (but not 5-hydroxytryptamine).
(ii) Differences between the stimulant actions
of the other compounds. It seemed that on the rat
fundus strip, the actions of 5-hydroxytryptamine and
tryptamlne were different, so an attempt was next
made to analyse the stimulant activity of some of
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the other compounds by observing the effects on this
activity of a substance which antagonised 5-hydroxy-
tryptamine rather than tryptamine. 2-Methyl-N-di-
methyltryptamine (16) and N-dimethyltryptamine (g)
were not really ideal for this purpose because they
could themselves cause contractions but bromo-
lysergic acid diethylamide seemed quite suitable
(Table 5). BAS (42), which might be regarded as
an obvious choice, was almost inactive on the rat
fundus strip.
Bromo-lysergic acid diethylamide was usually
ji
used in a concentration of 1.2 to 3.7 x 10 M. A
?
concentration of 1.2 x 10 M produced a dose ratio
greater than 10 for 5-hydroxytryptamine and less
than 10 for tryptaraine. Its effect took about 30
min. to develop and the preparation was used when it
had been exposed to the action of bromo-lysergic
acid for 1 hr. If the superfusion fluid was change
ed back to normal tyrode, the preparation recovered
in about 1 hr. Higher concentrations of bromo-
lysergic acid diethylamide increased the dose ratio
of 5-hydroxytryptamine without increasing that of
tryptamine. The significance of this is discussed
later (p. 119). These concentrations of bromo-
lysergic acid diethylamide, unlike similar concen¬
trations of lysergic acid diethylamide, did not
disturb the base line, but the contraction of the
Figure XXX
Hat fundus strip preparation
Effects of N-dimethyltryptaiaine (MegH) on responses to
6-hydroxytryptamine (HT)| tryptamine (T) and acetylcholine (Ach.).
Responses are shown to MeaH(6.6 n. Moles)J HT (5 & 10 ng.)j
T (8 and 16 u.g.) and ach. (40 and 80 jig.) alone and the combined
doses of Mean (6,6 n. Moles) with HT, 10 ngj T, 16 jxg. and Ach,
80 p,g. Hote that N-dimethyltryptamine reduces the effect of
5-hydroxytryptaiaine but increases those of T and Ach,
Eyoscine 2,3 and 10~7M in Tyrode solution.
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muscle, even in response to 5-hydroxytryptamine and
tryptamine took longer to develop. In these
experiments, a period of 3 min. was allowed (instead
of 90 sec.) for the contraction to be completed.
Table 5 shows the effects of bromo-lysergie acid
diethylamide on contractions produced by 5*methyl-
tryptamine (£0), N-dimethyltryptamlne (and N~di-
propyltryptamine (§) as well as by 5-hydroxytrypta-
mine and tryptamine. It seemed that the contract¬
ions produced by N-dimethyltryptamine (g), and N-
dipropyltryptamine (§) were like those produced by
5-hydroxytryptamine, whereas the effects of 5-
methyltryptamine (30) were more resistant to the
blocking effect of bromo-lysergic acid diethylamide
and thus resembled the effects of tryptamine.
Further evidence that the contractions produced
by N-dimethyltryptamine (£), were caused by an
action at the receptors where 5-hydroxytryptamine
acted, was obtained by the following experiments.
Responses were obtained with H-dixaethyltryptamine
(g), 6-hydroxytryptamine 10 ng., tryptamine 10 jig.
and acetylcholine 100 pg (a high dose because of
the presence of hyoseine in the tyrode solution
(see p.53). Mken 0.6 n Mol of N-dimethyltrypta-
mine (£) was added together with 10 ng of 5-
hydroxytryptamine, the response was less than that
previously obtained by 10 ng. of 5-hydroxytryptamine
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HT Stimulates ? No effect
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(Fig.XVI), but when 6,6 n Mol of N-dlmethyltrypta¬
mine (g) was added together with either 10 jig of
tryptamine or 100 jig of acetylcholine, the responses
were significantly increased.
These results were surprising. On the rat
fundus strip, N-diiaethyltryptaialne (g) antagonised
the effects of 5-hydroxytryptamine (without altering
the effect of tryptamine) but in higher concen¬
trations it caused contractions, apparently like
those of 6-hydroxytryptamine,
The situation could be explained by supposing
that there are separate tryptamine and 5-hydroxy-
tryptamine receptors and either that substances
like N-dimethyltryptamine (§) stimulate in high
concentration, a receptor, which they block in low
concentrationsj or that the 5-hydroxytryptamine
receptors are of two typesj one of which is blocked
by N-dimethyl tryptamine (£) in low concentrations
and the other stimulated by N-dimethyltryptamine (§)
in high concentrations. This scheme is illustrated
in Pig,opposite, Further, from the experiments with
bromo-lysergic acid diethylamide described on page
it would even seem possible that there are two
types of tryptamine receptors (because increasing
the concentration of bromo-lysergic acid diethyl-
amide above 3.7 x 10 M did not increase the block
of tryptamine). It is difficult to see why a
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substance should stimulate in high concentration a
receptor which it blocks in low concentration, but
before accepting the existence of two types of 5-
hydroxytryptamine receptors, it was decided to see
what would happen if a concentration of N-dimethyl-
tryptaraine (g) which caused stimulation was applied
to a preparation which was already under the
Influence of the blocking action of a lower concen¬
tration of the same substance. The result obtained
is shown in Fig.XII and there is no doubt that a
low concentration applied for a long time, antagon¬
ises the effects of a high concentration applied fofc
a short time. In these circumstances, there is
no reason to suppose the existence of two types of
6-hydroxytryptamine receptors.
(iil) Are there separate tryutamine and 5»
^^^tyyptapiine, recg.pto,y,g? At this stage of
the work, the results could be explained either by
supposing that there were separate tryptamine* and
5-hydroxytryptamine receptors in the rat fundus
strip or that there was only one type of receptor
"^The possibility of there being two types of T
receptors, was mentioned on p. and is discussed
in more detail on p.
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and that the antagonists studied blocked this
receptor at the same time as they blocked the des¬
truction of tryptamine.
Vane (1959) showed that the amine-oxidase inhib¬
itors, marsilid and phenylisopropyl hydrazine, pot¬
entiated the actions of some compounds, including
tryptamine, on the rat fundus strip but not the
actions of other compounds, including 5-hydroxy-
tryptamine. The compounds potentiated were all
substances which contained an oxidizable amino
group but did not contain a free phenolic hydroxyl
group. Vane showed that finely ground suspensions
of rat fundus would oxidise both 5-bydroxytryptamine
and tryptamine and suggested that tryptamine and
compounds like it, which lacked a free phenolic
group but contained an oxidizable NHa group, were
destroyed inside the cells by amine oxidase and so
potentiated by marsilid. 5~hydroxytryptamine and
other phenolic substances with an oxidizable NHa
group were not potentiated by marsilid and were not
destroyed because they did not penetrate the cell.
Substances which had no oxidizable NHS group were
likewise not potentiated by marsilid and not
destroyed by amine oxidase.
The compounds in Table 5, N-dimethyltryptamine
(2) and N-dlpropyltryptamine (5) which produced
contractions blocked by bromo-lysergic acid diethyl-
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TABLE 12
Stimulant activity of some indoles on
#
the rat fundus strip during the presence of Marsilld 3 x 10" M







































Effect of Marsllid on 5-kvdroxytryptamine







DOSE RATIOS AT THE END OF 45 MIN. FORs
5-Hydroxytryptamine Tryptamine Acetylcholine
4 x 10" 1 1 1 1
12 1 1 1 0.75
22 1 1 1 1
30 1 0.5 0.5 1
75 2 1 0.5 1
0.75 0.75
300 1 1 0.5 1
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amide, in a way similar to those produced by 5-
hydroxytryptaraine, were not potentiated by marsilid
(Vane, 1959), Contractions produced by 5-methyl-
tryptamine (30) however, resembled those produced
by tryptamine, they were less easily blocked by
bromo-lysergic acid diethylamide than those of 5-
hydroxytryptamine and were potentiated by marsilid.
fable 12 shows results obtained which confirmed
Vane*s (1959) findings. In these experiments,
marsilid x 10 M was added to the tyrode (which
already contained hyoscine 2.3 x 10*" M). The
contractions caused by 5-hydroxytryptamine (doses
of 10-20 ng. were used) were unaffected. They
were complete within 90 sec. and the base line was
normal after about 1 min. stretching. Contractions
caused by N-dimethyltryptaaine (g) were also un-
I
affected by marsilid but, as on the normal prepar¬
ation, took 120 sec. for completion and required
2-3 min. stretching for recovery. Contractions
caused by tryptamine and S-methyltryptamine (30)
were potentiated by marsilid and required longer
time for stretching and recovery than in normal
tyrode, They resembled the contractions produced
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MLE 1%
Antagonistic activity of bromo-lysergie acid
diethylamide and some analogues to 5-hydroxytryptamine,
5-methyltryptamine and tryptamine responses on the rat
fundus strip during the presence of Marsilid (3 x 10-&M)













































- means not tested.
Rat fundus strip preparation
Antagonistic effect of 2-methyl-N-dimethyltryptamine
(2MeNMe3) in the presence of Marsilld 3 x 10"8M in Tyrode solution.
Responses are shown to 5-hydroxytryptamlne (HT, 5» 50 and 100 ng.)j
tryptaralne (T, 200 ng. 2 and 4 p,g.) and acetylcholine (Acli. 10 p,g.)
before and after the action of the analogue in a concentration of
2 x 10-6M for 1 hr, Rote that at the end of the experiment, the
responses to both 5-HT and T are equally depressed.
Hyoscine 2«3x 10~'7M used in Tyrode solution.
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by M-dimethyltryptaisine (3)t
It seemed possible therefore, that the results
could all be explained by supposing that substances
which blocked 5-hydroxytryptamine more than trypta-
mine were really only blocking one receptor (affect-*
ed by either 5-hydroxytryptamine and tryptaraine) and
simultaneously blocking amine oxidase and thus
potentiating tryptamine.
If this were so, the substances which antagon¬
ised 5-hydroxytryptamine more than tryptamine shoulc
antagonise both equally when an amine oxidase inhib¬
itor was present. Table 13 shows dose ratios
obtained in the presence of aarsilld. Bromo-
lyserglc acid diethylamide, 2-methyl-H-dimethyl-
tryptamine (16) and N-dimethyl tryptamine (3) antag¬
onised 5-hydroxytryptamlne, tryptamine and, in two
experiments with bromo-lysergic acid diethylamide,
5-methyltryptamine (£0), to the same extent, thus
supporting the idea set out above.
The experiment described on page in,in which
N-dimethyltryptamine (3) was added in a high dose
to 5-hydroxytryptamine, tryptamine and acetylcholine
was repeated in the presence of marsilld, Con-
#Control responses to 5-hydroxytryptamine were not
disturbed in these experiments by tryptamine and 5-
methyltryptamine (£0) but after I-dimethyltryptamin^
[ £), they were depressed for 15-30 min. This i3 much
longer than the depression (usually lasting 5 min.)
caused by similar doses in the absence of marsilid.
This may be caused (at least in part) by the need to
use twice the dose when marsilid is present.
Figure XXIII
Hat fundus strip preparation
Effects of N-dimethyltryptaraine (MeaN) on response to
5-hydroxytryptaiaine (HT): tryptamine (T) and acetylcholine (Ach.)
in the presence of Marsilid 3 x 10-8M in Tyrode solution.
Responses are shown in MeaN (33 nM), HT (10 and 20 ng,)j
T (200 and 500 ng.) and Ach, (5 and 10 p.g.) alone and the combined
doses of Me3N (33 nM) with HT 20 ng$ T, 500 ng. and Ach, 10 yg.
Note the N-diraethyltryptamine reduces the effects of HT and T to
an equal extent but increases that of Ach.
Hyoscine 2,3 x 10"7M used in Tyrode solution.
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tractions were produced with 20 ng. of 5-hydroxy-
tryptamine, 500 ng, of tryptamine and 10 ^g. of
acetylcholine. N-Dimethyltryptamine (3) (33 n Mol
produced a contraction and when added at the same
time as the doses of 5-hydroxytryptamine or trypta¬
mine reduced the response, whereas it increased the
response to acetylcholine (Fig.XXIII).^his result
again supports the idea that there is only one
receptor and that some compounds antagonise 5-
hydroxytryptamine more than tryptamine because they
decrease the destruction of tryptamine at the same
time as "blocking the receptors.
iv. Are there two tryptamine-receutors in the
rat fundus strip? Although in the rat fundus strip
the evidence so far is that the 5-hydroxytryptamine
is a tryptamine receptor, there remains the possi¬
bility from the experiments described on page 112,
that there may be two types of tryptamine-receptors
one, blocked by bromo-lysergic acid diethylamide in
7
concentration from 1.2 - 3.7 x 10** M and apparently
the receptor where 6-hydroxytryptamine acts, and
another which is not blocked by bromo-lysergic acid
diethylamide.
In the guinea pig ileum there are also supposed
to he two types of receptors. On one, the response
to 5-hydroxytryptamine are blocked by bromo-lysergio
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acid diethylamide (Gaddum and Picarelli, 1957) and
it has been shown (p. 95) that, on this receptor,
the responses to tryptamine are similar to those of
5-hydroxytryptamine.
By analogy, the second type of receptor in the
rat fundus strip might be compared with the morphine
sensitive receptor in the guinea pig ileum, Howeve
morphine did not antagonise the effects of 5~
hydroxytryptamlne and tryptamine on a preparation
treated with a high concentration of bromo-lysergic
.,6
acid diethylamide (2,5 x 10 M). In this experiment,
byoseine was omitted from the tyrode. As a check
the effects of bromo-lysergic acid diethylamide on
the responses to 5-hydroxytryptamine and tryptamine
were studied using normal tyrode and found to be
the same as before. From these results, it did no'
appear that the second type of tryptamine-receptor
in the rat fundus strip could be compared with the





Pictorial summary of results in Table 1
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These compounds were also tested and found to be antagonists
of 5-hydroxytryptamine on the "D" receptors (in the presence of morphine),
of the guinea pig ileum. The order of their activity was the same as
on the rat uterus, but had no such effect on the receptors (di-
benzyline treated) of the guinea pig ileum.
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PISCUSSIOH
The compounds with any degree of antagonistic
activity are summarised in Table 14 and the variation
of stimulant activity with structure is summarised
in Flgs.G and H.
In the 5-hydroxydialkyltryptamines, on both the
rat uterus and rat fundus, stimulant activity de¬
clined as the size of the alkyl group was increased
although, on both tissues, the di-isopropyl com¬
pound (24) was more active than might be expected*
In the 5-hydroxydlbutyl compound (25) stimulant
activity was very greatly reduced but, on the rat
uterus, this compound had marked antagonistic
activity suggesting that it had affinity but little
or no efficacy.
In the dialkyltryptamines the variation of
activity with structure was different from what it was
with the 5-hydroxy compounds. On both preparetion$
there was a rise up the series to the dipropyl com¬
pounds (§) followed by a fall but the results on the
two preparations differed in two aspects. First,
relative to tryptamine, the compounds were very much
more active on the rat fundus than on the rat uteru$.
Second, on the rat uterus, the dimethyl compound (3)
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had a very low stimulant activity. This compound
was a moderate antagonist on both tissues.
The three raonoalkyIt ryptamines( 3^,2,4, and 1&)
studied, appeared to resemble the tryptamines rather
than 5~hydroxytryptamlnes in their stimulant activi
ty, On the rat fundus however, the ethyl compound
(14) was the most active and the methyl compound (13)
was very feeble, but on the rat uterus, where di¬
methyltryptamine (£) was very feeble, methyltrypta-
mlne (is) was about as active as the ethyl (J^D and
propyl compounds (15). A 2-metbyl group appeared
to reduce both the stimulant and antagonistic
activity} the stimulant properties of the 2-iaethyl
compounds (16,17 and JS) was less than those of the
simple dlalkyltryptamines on both the rat uterus and
rat fundus, and the antagonistic activity of 2-
raethyl-diroethyltryptamine (16) was less than that
of dimethyltryptamlne (g) on both the tissues.
On the rat uterus, the 5-benzyloxy compounds
S§) were antagonists but their antagonistic
activity varied with the structure in the same way
as did the stimulant activity of the dlalkyltrypta-
mines (but not in the same way as did the stimulant
activity of the 5-hydroxytryptamines). On the rat
fundus strip, the 5-benzyloxy compounds were stimu¬
lants but the variation of activity with structure
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resembled more that of the monoalkyltryptamines than
that of the dlalkyltryptamln.es and did not at all
resemble that of 5-hydroxytryptamines.
Before proceeding to assess the significance of
these findings, it is first necessary to make some
attempt to decide the part played by amine oxidase,
or any other detoxicating enzymes, and also to
decide how far the receptors may be different in the
different preparations,
Effects of amine oxidase.
Vane (1959) showed the existence of amine
oxidase in the rat fundus strip and that marsilid
potentiated the action of certain compounds which
might be substrates of this enzyme, Marsilid did
not change the sensitivity of the rat uterus to 5-
hydroxytryptamine and tryptamine (Table 12) ,but when
ground, this tissue contained even more amine oxi¬
dase activity than the rat fundus (Barlow, unpublish¬
ed). Strips of rat fundus were incubated for 1 hr.
with tryptamine (1,2 mg, base/ml. and 120 pg./ml.)
•• • ■ ;
and the activity of the solution compared on the
rat fundus strip with that of a control kept at 4cC,
for 1 hrt The destruction of tryptamine/fundus/hr,
was (mean of 8 experiments 1 S.E.) 52 J in the
higher concentration and 93 t 4.% in the lower con¬
centration. These figures agree quite well with
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the results obtained by Vane (1959) from the oxygen
uptake of ground fundus suspensions. However,
there was also a destruction of S-hydroxytryptamine
when this was incubated in ©quimolar concentration
(2.3 mg. creatinine sulphate/ml and 230 pg/ml)
under similar conditions. The rates were 47 t 4$
and 74 t Although this is significantly
slower at the lower concentration than the rate of
destruction of tryptamine, larger amounts of trypta
mine than of 5-hydroxytryptamine are needed to
cause contractions. It is possible that these
results are misleading and that, in the concen¬
trations which affect the rat fundus strip, the
destruction of tryptamine by amine oxidase is pro¬
portionately greater than that of 5-hydroxytrypta-
mine, hut it is certainly not what would be expects
ed, because the 5-hydroxytryptamine concentration
in the bath is about one-thousandth of the trypta¬
mine concentration and in the incubation experiments
the enzyme appeared to be proportionately more
effective with very low concentrations of substrata.
Another very puzzling finding was that, in
manometric experiments, bromo-lysergic acid diethyl-
amide in a concentration as high as 3 x 10" M had
only slight effects (about 15^ inhibition) on the
oxidation of tryptamine by suspensions of ground
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rat fundus. A concentration of 10 M marsilid
caused 60$ inhibition of this oxidation. (Vane
used 3 x 10 M raarsilid to demonstrate the potenti¬
ation of tryptamine on the rat fundus strip). It
is difficult, therefore, unless Vane (1969) used
unnecessarily high concentrations of marsilid, to
believe that the concentrations of bromo-lysergic
acid diethylamide (around 3 x 10 M) which antagon¬
ised 6-hydroxytryptamine more than tryptamine could
also have a significant effect on the destruction
of tryptamine alone. Again the difficulty arises
that if the results of the incubation experiments
mean anything, 5-hydroxytryptamine should be more
susceptible to attack by amine oxidase than trypta¬
mine, consequently a block of amine oxidase could
not explain the results.
With such apparently contradictory results it
is extremely difficult to come to any definite con-
elusions which are likely to be of any value. In
the rat fundus strip amine oxidase does seem to
play a part in the mechanism of action of trypta¬
mine and in the rat uterus, although there is plenty
of amine oxidase it does not seem to influence the
actions of 6-hydroxytryptamine or tryptamine. This
follows from the potentiation of tryptamine by
marsilid on the rat fundus but not the rat uterus.
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It would explain why o-methyltryptamines (18) and
such substances as N-dipropyl-tryptamine (£) are
much more active relative to tryptamine on the rat
fundus than on the rat uterus. It would also explain
why H-methyltryptamine (3^2), which is a substrate
of amine oxidase (Gcvier# Howes and Gibbon, 1953),
is only feebly active on the rat fundus strip com¬
pared with the higher homologues, which should be
less susceptible to destruction by amine oxidase.
Vane (1959) found that the activity of H-iuethyl-
tryptamine (13) on the rat fundus strip was greatly
potentiated by marsilid. On the rat uterus, the
substances all had about the same activity, 5*
Hydroxy-a-methyltryptamin© (20) and 5-hydroxy-H-
dipropyl-tryptamine (23) were not, however, more
active than 5-hydroxytryptamine on either the rat
uterus or the rat fundus, and, relative to 5-
hydroxytryptamine, the 5-hydroxy compounds had the
same order of activity on both tissues. It seems
unlikely, therefore, that they are destroyed by
amine oxidase to any extent. This would imply
either that they do not have access to amine oxidase
or that they are destroyed more rapidly by some
other system. The destruction of 5-hydroxytrypta-
mine by strips of rat fundus might be an action of
a phenol oxidase not blocked by marsilid, This must
obviously be investigated, The ability of a
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substance to antagonise 5-hydroxy tryptamine more
than tryptamine on the rat fundus strip seems to
depend upon different mechanisms for the destruction
of 5-hydroxytryptamine and tryptamine in spite of
what might be expected from the results obtained in
the manometric experiments with bromo-lysergic acid
diethylamide and suspensions of ground fundus#
Again, these effects disappeared when the prepara¬
tion is treated with marsilid, which makes it very
difficult to believe that the differentiation is
anything except a consequence of a block of the
destruction of tryptamine.
Differences between the sensitivities of different
tissues.
The relative stimulant activities of the
compounds on the rat uterus and rat fundus strip
were not all that dissimilar and the differences
may, in part at least, be ascribed to the actions
of certain of the compounds on amine oxidase in the
rat fundus. Such results as have been obtained on
the "D" receptors of the guinea pig ileum were simi¬
lar to those obtained on the rat uterus. Effects on
the MM" receptors of the guinea pig ileum and on the
rabbit ear preparation seemed to be quite different
from each other and from the other tissues.
There were, however, considerable differences
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in the antagonistic activity of the compounds on the
rat fundus and rat uterus. Brono-lysergic acid
diethylamide and 5-benzyloxygramine (41) are much
less active on the rat fundus than on the rat uteru$
(the same dose ratios to 5-hydroxytryptamine were
produced by 9 x 10 M S-bensyloxygramine (41) on
the rat uterus and 2 x 10 M 5»benzyloxygramine (41)
_ 8
on the rat fundus and by 10 X bromo*lysergic acid
diethylamide on the rat uterus and 10 M bromo-
lysergic acid diethylamide on the rat fundus). N-
Dimethyltryptamine (g), S~benzyloxy-$-dimethyl-
tryptamine (32) and 2-methyl-dimethyltryptaslne (16
however) were more active on the rat fundus than on
the rat uterus. On the "D" reeeptors of the guine^
pig ileum the activities of the antagonists studied
were similar to those on the rat uterus. these
results suggest that bromo-lysergic acid diethyl¬
amide and &-benzyloxygramine (41) may act different¬
ly from N-dimethyltryptamine (g), 5-benzyloxy-N-di-
methyltryptamine (32) and S-methyl-N-dimethyltrypta
mine (16).
5-Hydroxvtrvptamine and tryptamine receptors.
the pharmacological results can be adequately
explained on the assumption that 5-hydroxytryptamine
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TABLE 15
Eguipotent molar ratios of some tryptamlnes









During the presence 8












2 Tryptamine 933 32 210
3 N-dimethyl-
tryptamine 350 110 1000
4 N-diethyl-
tryptamine 112 87 500
5 N-dipropyl-
tryptamin© 40 41 200
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and tryptamine act on the same receptors exeept
for i-
1. The effects of increasing the concentration
of bromo-lyserglc acid diethylamide on the response
of the rat fundus to tryptamine (p. 112).
2, The absence of any appreciable action of
bromo-lysergic acid diethylamide in preventing the
destruction of tryptamjne by suspensions of ground
rat fundus.
6. The destruction of 5-hydroxytryptamine by
strips of rat fundus.
However, the relationships between structure
and activity of the tryptamines resemble those of
the 2-methyltryptamines but are quite different
from those of the 5-hydroxy compounds. Although
the activity of the tryptamines can be regarded as
having two components the intrinsic activity on the
receptors and the effect due to inhibition of amine
oxidase, Vane»s (1959) figures for the relative
activity on a preparation treated with marsilid
indicate (Table 15) that the peak in activity at
dipropyltryptamine (&) is a real peak, not simply
the result of amine oxidase block by that compound*
In these circumstances, it seems doubtful
whether the compounds really are all acting on the
same receptor. Although the results can be
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explained using only one receptor, it may be that
after all, there are 2 receptors. At the moment,
there is not enough experimental evidence to justify
a great deal of speculation about this.
Future work.
To obtain some idea of the eentral actions
of these compounds it will be necessary to study them
systematically on intact animals or human beings.
There does not seem to be any real justification for
attempting to predict their effects from the results
of these in vitro tests. Toxicity studies are
planned for 2-aethyl-N-dimethyltryptamine (16) and
N-dipropyltryptamine (§), which have been prepared
in sufficient quantity for human trial. An investi¬
gation of the effects on the duration of sleep
produced by hexobarbitone in mice was begun but was
stopped because it was known that Dr. Vane was work¬
ing on this. Further synthetic work should be
directed towards the following
5-hydroxy di-igo-, di-sec, and di-tert- butyl-
amines and di-amyl compounds. The actions of the
compounds in antagonising the effects of nicotine
and histamine on the guinea pig ileum and the effects







aminoethyl)-5-hydroxy- indoles and their 3-(2-amino
n-propyl)- analogues have been studied for their
ability to modify or imitate the actions of 5-
hydroxytryptamine. All the compounds were tested
on the isolated rat uterus and rat fundus strip
preparations, some of them were also tested on the
isolated guinea pig ileum, and a few were tested or,
the isolated perfused rabbit*s ear preparation.
Most of the compounds imitated the actions of
5-hydroxytryptamlne and only a few antagonised then
None was a particuarly active antagonist, the most
powerful on the rat uterus being 3-(2-amino-n-
propy3)-5-benzyloxy indole but this was not as
active as 5-benzyloxygramine whose ability to ant¬
agonise 5-hydroxytryptamine has been known for som^
time. On the rat fundus strip, however, 3-(2-di¬
me thy laminoethyl) - and 3-)2-dimethylaminoethyl)-5-
benzyloxyindoles, which were the most active, were
about ten times as active as 5-benzyloxygramine,
Most of the compounds caused contractions of
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the rat uterus and rat fundus strip preparations.
Those compounds which antagonised the contraction^
produced by 5-hydroxytryptamine themselves caused
contractions when given in higher concentrations.
The most active stimulant on the rat uterus and
rat fundus strip was 3-(2-amino-n-propyl)-5-
hydroxyindole, the next most potent was 3-dime thy],-
aminoethyl)-5-hydroxyindole, These were about
half as active as 5-hydroxytryptamine.
The relationships between the structure and
activity of the compounds with a 5-hydroxyl group
were different from those of the other compounds.
The former can be regarded as true analogues of
5-hydroxytryptamine whereas the latter may be
more appropriately regarded as analogues of
tryptamine.
Although 5-hydroxytryptamine and tryptamine
both cause contraction of the preparation used,
there is some doubt whether these substances act
in exactly the same way. The actions of trypta¬
mine have been compared with those of 5-hydroxy-
tryptamine on all the tissues. Some of the
antagonists appeared to antagonise 5-hydroxy-
tryptamine more than tryptamine and possible
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explanations of this are given. The nature of
the stimulant action of the new compounds has also
been studied.
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